Significant New Use Rules on Certain Chemical Substances, 50838-50849 [2018-21871]
Download as PDF
50838
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
(i) That debts over 120 days
delinquent and eligible for the
centralized administrative offset
collection actions described in
paragraph (a)(6)(i) of this section must
be referred to the FMS for collection
(see §§ 1011.10 through 1011.12);
(ii) That debts over 180 days
delinquent not previously referred to
the FMS under paragraph (a)(7)(i) of this
section must be referred to the FMS for
cross servicing debt collection (see
§ 1011.9).
*
*
*
*
*
25. Revise § 1011.9(a) to read as
follows:
■
(a) Cross-servicing. Unless a
delinquent debt has previously been
transferred to the FMS for
administrative offset in accordance with
§ 1011.10, the Presidio Trust will
transfer any eligible debt that is more
than 180 days delinquent to the FMS for
debt collection services, a process
known as ‘‘cross-servicing.’’ The
Presidio Trust may transfer debts
delinquent 180 days or less to the FMS
in accordance with the procedures
described in 31 CFR 285.12. The FMS
takes appropriate action to collect or
compromise the transferred debt, or to
suspend or terminate collection action
thereon, in accordance with the
statutory and regulatory requirements
and authorities applicable to the debt
and the collection action to be taken.
Appropriate action includes, without
limitation, contact with the debtor,
referral of the debt to the Treasury
Offset Program, private collection
agencies or the Department of Justice,
reporting of the debt to credit bureaus,
and administrative wage garnishment.
*
*
*
*
*
26. Revise § 1011.10(a)(1) to read as
follows:
■
daltland on DSKBBV9HB2PROD with RULES
§ 1011.10 How will the Presidio Trust use
administrative offset (offset of non-tax
federal payments) to collect a debt?
(a) Centralized administrative offset
through the Treasury Offset Program. (1)
The Presidio Trust will refer any eligible
debt over 120 days delinquent to the
Treasury Offset Program for collection
by centralized administrative offset. The
Presidio Trust may refer any eligible
debt less than 120 days delinquent to
the Treasury Offset Program for offset.
*
*
*
*
*
16:31 Oct 09, 2018
Jkt 247001
[FR Doc. 2018–21969 Filed 10–9–18; 8:45 am]
BILLING CODE 4310–4R–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Parts 9 and 721
[EPA–HQ–OPPT–2018–0649; FRL–9984–65]
RIN 2070–AB27
Significant New Use Rules on Certain
Chemical Substances
Environmental Protection
Agency (EPA).
ACTION: Direct final rule.
AGENCY:
§ 1011.9 When will the Presidio Trust
transfer a debt to the Financial Management
Service for collection?
VerDate Sep<11>2014
Dated: October 3, 2018.
Nancy J. Koch,
General Counsel.
EPA is promulgating
significant new use rules (SNURs) under
the Toxic Substances Control Act
(TSCA) for 28 chemical substances
which were the subject of
premanufacture notices (PMNs). The
chemical substances are subject to
Orders issued by EPA pursuant to
section 5(e) of TSCA. This action
requires persons who intend to
manufacture (defined by statute to
include import) or process any of these
28 chemical substances for an activity
that is designated as a significant new
use by this rule to notify EPA at least
90 days before commencing that
activity. The required notification
initiates EPA’s evaluation of the
intended use within the applicable
review period. Persons may not
commence manufacture or processing
for the significant new use until EPA
has conducted a review of the notice,
made an appropriate determination on
the notice, and has taken such actions
as are required with that determination.
DATES: This rule is effective on
December 10, 2018. For purposes of
judicial review, this rule shall be
promulgated at 1 p.m. (e.s.t.) on October
24, 2018.
Written adverse comments on one or
more of these SNURs must be received
on or before November 9, 2018 (see Unit
VI. of the SUPPLEMENTARY INFORMATION).
If EPA receives written adverse
comments, on one or more of these
SNURs before November 9, 2018, EPA
will withdraw the relevant sections of
this direct final rule before its effective
date.
For additional information on related
reporting requirement dates, see Units
I.A., VI., and VII. of the SUPPLEMENTARY
INFORMATION.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
SUMMARY:
PO 00000
Frm 00034
Fmt 4700
Sfmt 4700
number EPA–HQ–OPPT–2018–0649, by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute.
• Mail: Document Control Office
(7407M), Office of Pollution Prevention
and Toxics (OPPT), Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Kenneth Moss, Chemical Control
Division (7405M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: (202) 564–9232;
email address: moss.kenneth@epa.gov.
For general information contact: The
TSCA—Hotline, ABVI-Goodwill, 422
South Clinton Ave. Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA—Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you manufacture, process,
or use the chemical substances
contained in this rule. The following list
of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Manufacturers or processors of one
or more subject chemical substances
(NAICS codes 325 and 324110), e.g.,
chemical manufacturing and petroleum
refineries.
This action may also affect certain
entities through pre-existing import
certification and export notification
rules under TSCA. Chemical importers
are subject to the TSCA section 13 (15
U.S.C. 2612) import certification
E:\FR\FM\10OCR1.SGM
10OCR1
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
requirements promulgated at 19 CFR
12.118 through 12.127 and 19 CFR
127.28. Chemical importers must certify
that the shipment of the chemical
substance complies with all applicable
rules and orders under TSCA. Importers
of chemicals subject to these SNURs
must certify their compliance with the
SNUR requirements. The EPA policy in
support of import certification appears
at 40 CFR part 707, subpart B. In
addition, any persons who export or
intend to export a chemical substance
that is the subject of this rule on or after
November 9, 2018 are subject to the
export notification provisions of TSCA
section 12(b) (15 U.S.C. 2611(b)) (see
§ 721.20), and must comply with the
export notification requirements in 40
CFR part 707, subpart D.
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit this
information to EPA through
REGULATIONS.GOV or email. Clearly mark
part or all of the information that you
claim to be CBI. For CBI information in
a disk or CD–ROM that you mail to EPA,
mark the outside of the disk or CD–ROM
as CBI and then identify electronically
within the disk or CD–ROM the specific
information that is claimed as CBI. In
addition to one complete version of the
comment that includes information
claimed as CBI, a copy of the comment
that does not contain the information
claimed as CBI must be submitted for
inclusion in the public docket.
Information so marked will not be
disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments.
When preparing and submitting your
comments, see the commenting tips at
https://www.epa.gov/dockets/
comments.html.
II. Background
daltland on DSKBBV9HB2PROD with RULES
A. What action is the agency taking?
1. Direct Final Rule. EPA is
promulgating these SNURs using direct
final rule procedures. These SNURs will
require persons to notify EPA at least 90
days before commencing the
manufacture or processing of a chemical
substance for any activity designated by
these SNURs as a significant new use.
Receipt of such notices obligates EPA to
assess risks that may be associated with
the significant new uses under the
conditions of use and, if appropriate, to
regulate the proposed uses before they
occur.
2. Proposed Rule. In addition to this
Direct Final Rule, elsewhere in this
issue of the Federal Register, EPA is
issuing a Notice of Proposed
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
Rulemaking for this rule. If EPA receives
no adverse comment, the Agency will
not take further action on the proposed
rule and the direct final rule will
become effective as provided in this
action. If EPA receives adverse comment
on one or more of SNURs in this action
by October 25, 2018 (see Unit VI. of the
SUPPLEMENTARY INFORMATION), the
Agency will publish in the Federal
Register a timely withdrawal of the
specific SNURs that the adverse
comments pertain to, informing the
public that the actions will not take
effect. EPA would then address all
adverse public comments in a response
to comments document in a subsequent
final rule, based on the proposed rule.
B. What is the agency’s authority for
taking this action?
Section 5(a)(2) of TSCA (15 U.S.C.
2604(a)(2)) authorizes EPA to determine
that a use of a chemical substance is a
‘‘significant new use.’’ EPA must make
this determination by rule after
considering all relevant factors,
including the four bulleted TSCA
section 5(a)(2) factors listed in Unit III.
Once EPA determines that a use of a
chemical substance is a significant new
use, TSCA section 5(a)(1)(B) requires
persons to submit a significant new use
notice (SNUN) to EPA at least 90 days
before they manufacture or process the
chemical substance for that use (15
U.S.C. 2604(a)(1)(B)(i)). TSCA
furthermore prohibits such
manufacturing or processing from
commencing until EPA has conducted a
review of the notice, made an
appropriate determination on the notice,
and taken such actions as are required
in association with that determination
(15 U.S.C. 2604(a)(1)(B)(ii)). As
described in Unit V., the general SNUR
provisions are found at 40 CFR part 721,
subpart A.
C. Applicability of General Provisions
General provisions for SNURs appear
in 40 CFR part 721, subpart A. These
provisions describe persons subject to
the rule, recordkeeping requirements,
exemptions to reporting requirements,
and applicability of the rule to uses
occurring before the effective date of the
rule. Provisions relating to user fees
appear at 40 CFR part 700. According to
§ 721.1(c), persons subject to these
SNURs must comply with the same
SNUN requirements and EPA regulatory
procedures as submitters of PMNs under
TSCA section 5(a)(1)(A). In particular,
these requirements include the
information submission requirements of
TSCA section 5(b) and 5(d)(1), the
exemptions authorized by TSCA section
5(h)(1), (h)(2), (h)(3), and (h)(5), and the
PO 00000
Frm 00035
Fmt 4700
Sfmt 4700
50839
regulations at 40 CFR part 720. Once
EPA receives a SNUN, EPA must either
determine that the significant new use
is not likely to present an unreasonable
risk of injury or take such regulatory
action as is associated with an
alternative determination before the
manufacture or processing for the
significant new use can commence. If
EPA determines that the significant new
use is not likely to present an
unreasonable risk, EPA is required
under TSCA section 5(g) to make public,
and submit for publication in the
Federal Register, a statement of EPA’s
findings.
III. Significant New Use Determination
Section 5(a)(2) of TSCA states that
EPA’s determination that a use of a
chemical substance is a significant new
use must be made after consideration of
all relevant factors, including:
• The projected volume of
manufacturing and processing of a
chemical substance.
• The extent to which a use changes
the type or form of exposure of human
beings or the environment to a chemical
substance.
• The extent to which a use increases
the magnitude and duration of exposure
of human beings or the environment to
a chemical substance.
• The reasonably anticipated manner
and methods of manufacturing,
processing, distribution in commerce,
and disposal of a chemical substance.
In addition to these factors
enumerated in TSCA section 5(a)(2), the
statute authorizes EPA to consider any
other relevant factors.
To determine what would constitute a
significant new use for the 28 chemical
substances that are the subject of these
SNURs, EPA considered relevant
information about the toxicity of the
chemical substances, likely human
exposures and environmental releases
associated with possible uses, and the
four bulleted TSCA section 5(a)(2)
factors listed in this unit.
IV. Substances Subject to This Rule
EPA is establishing significant new
use and recordkeeping requirements for
28 chemical substances in 40 CFR part
721, subpart E. In this unit, EPA
provides the following information for
each chemical substance:
• PMN number.
• Chemical name (generic name, if
the specific name is claimed as CBI).
• Chemical Abstracts Service (CAS)
Registry number (if assigned for nonconfidential chemical identities).
• Basis for the TSCA section 5(e)
Order.
• Information identified by EPA that
would help characterize the potential
E:\FR\FM\10OCR1.SGM
10OCR1
daltland on DSKBBV9HB2PROD with RULES
50840
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
health and/or environmental effects of
the chemical substance in support of a
request by the PMN submitter to modify
the Order, or if a manufacturer or
processor is considering submitting a
SNUN for a significant new use
designated by the SNUR.
This information may include testing
required in a TSCA section 5(e) Order
to be conducted by the PMN submitter,
as well as testing not required to be
conducted but which would also help
characterize the potential health and/or
environmental effects of the PMN
substance. Any recommendation for
information identified by EPA was
made based on EPA’s consideration of
available screening-level data, if any, as
well as other available information on
appropriate testing for the chemical
substance. Further, any such testing
identified by EPA that includes testing
on vertebrates was made after
consideration of available toxicity
information, computational toxicology
and bioinformatics, and highthroughput screening methods and their
prediction models. EPA also recognizes
that whether testing/further information
is needed will depend on the specific
exposure and use scenario in the SNUN.
EPA encourages all SNUN submitters to
contact EPA to discuss any potential
future testing. See Unit VIII. for more
information.
• CFR citation assigned in the
regulatory text section of this rule.
The regulatory text section of these
rules specifies the activities designated
as significant new uses. Certain new
uses, including exceedance of
production volume limits (i.e., limits on
manufacture volume) and other uses
designated in this rule, may be claimed
as CBI. Unit IX. discusses a procedure
companies may use to ascertain whether
a proposed use constitutes a significant
new use.
These rules include 28 PMN
substances that are subject to Orders
under TSCA section 5(e)(1)(A). Each
Order is based on one or more of the
findings in TSCA section 5(a)(3)(B):
there is insufficient information to
permit a reasoned evaluation; in the
absence of sufficient information to
permit a reasoned evaluation, the
activities associated with the PMN
substances may present unreasonable
risk to human health or the
environment; the substance is or will be
produced in substantial quantities, and
enters or may reasonably be anticipated
to enter the environment in substantial
quantities or there is or may be
significant (substantial) human
exposure to the substance. Those Orders
require protective measures to limit
exposures or otherwise mitigate the
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
potential unreasonable risk. The SNURs
identify as significant new uses any
manufacturing, processing, use,
distribution in commerce, or disposal
that does not conform to the restrictions
imposed by the underlying Orders,
consistent with TSCA section 5(f)(4).
Where EPA determined that the PMN
substance may present an unreasonable
risk of injury to human health via
inhalation exposure, the underlying
TSCA section 5(e) Order required,
among other things, that potentially
exposed employees wear specified
respirators unless actual measurements
of the workplace air show that air-borne
concentrations of the PMN substance
are below a New Chemical Exposure
Limit (NCEL) that is established by EPA
to provide adequate protection to
human health. In addition to the actual
NCEL concentration, the comprehensive
NCELs provisions in TSCA section 5(e)
Orders, which are modeled after
Occupational Safety and Health
Administration (OSHA) Permissible
Exposure Limits (PELs) provisions,
include requirements addressing
performance criteria for sampling and
analytical methods, periodic
monitoring, respiratory protection, and
recordkeeping. However, no comparable
NCEL provisions currently exist in 40
CFR part 721, subpart B, for SNURs.
Therefore, for these cases, the
individual SNURs in 40 CFR part 721,
subpart E, will state that persons subject
to the SNUR who wish to pursue NCELs
as an alternative to the § 721.63
respirator requirements may request to
do so under § 721.30. EPA expects that
persons whose § 721.30 requests to use
the NCELs approach for SNURs that are
approved by EPA will be required to
comply with NCELs provisions that are
comparable to those contained in the
corresponding TSCA section 5(e) Order
for the same chemical substance.
PMN Numbers: P–15–442, P–15–443,
P–15–444, P–15–445, P–15–446, P–15–
447, P–15–525, P–15–526, P–15–527,
and P–15–528.
Chemical names: Rare earth doped
zirconium oxide (generic).
CAS numbers: Not available.
Effective date of TSCA section 5(e)
Order: January 25, 2018.
Basis for TSCA section 5(e) Order:
The PMNs state that the generic (nonconfidential) use of the substances will
be as catalysts. EPA identified concern
for lung toxicity and oncogenicity based
on analogy to respirable poorly soluble
particulates and the crystalline structure
of the substances. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
PO 00000
Frm 00036
Fmt 4700
Sfmt 4700
substances may present an unreasonable
risk of injury to human health and the
environment. The order was also issued
under TSCA sections 5(a)(3)(B)(ii)(II)
and 5(e)(1)(A)(ii)(II), based on a finding
that the substances will be produced in
substantial quantities and that the
substances either enter or may
reasonably be anticipated to enter the
environment in substantial quantities,
or there is or may be significant (or
substantial) human exposure to the
substances. To protect against these
risks, the Order requires:
1. Submit to EPA certain toxicity
testing for both P–15–443 and P–15–445
within the 18 and 60-month time limits
specified on the Order.
2. Use of a National Institute of
Occupational Safety and Health
(NIOSH)-certified respirator with an
assigned protection factor (APF) of at
least 1,000 where there is a potential for
inhalation exposure or compliance with
a NCEL of 0.07 mg/m3 as an 8-hour
time-weighted average to prevent
inhalation exposure;
3. Establishment and use of a hazard
communication program, including
human health precautionary statements
on each label and in the safety data
sheet (SDS).
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the health effects of the PMN
substances may be potentially useful to
characterize the effects of the PMN
substances in support of a request by the
PMN submitter to modify the Order, or
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that would be
designated by this SNUR. The submitter
has agreed not to exceed the time limits
in the Order without performing
specific pulmonary toxicity testing and
carcinogenicity testing on PMN
substances P–15–443 and P–15–445.
CFR citation: 40 CFR 721.11173.
PMN Numbers: P–16–194, P–16–195,
P–16–196, P–16–197, P–16–198, P–16–
199, P–16–460, P–16–461, P–16–462, P–
16–463, and P–16–464.
Chemical names: Silane-treated
aluminosilicate (generic).
CAS numbers: Not available.
Effective date of TSCA section 5(e)
Order: January 22, 2018.
Basis for TSCA section 5(e) Order:
The PMNs state that the generic (nonconfidential) use of the substances will
be as process aids. Based on analysis of
test data on the PMN substances, EPA
identified human health concerns for
cancer and non-cancer chronic toxicity
effects associated with the metal
E:\FR\FM\10OCR1.SGM
10OCR1
daltland on DSKBBV9HB2PROD with RULES
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
impurities found in the PMN
substances. Environmental effects were
identified for the metal constituents in
the PMN substances. The Order was
issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substances may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
1. Submit to EPA metals content
analysis of the material used to
manufacture the PMN substances.
2. Provide personal protective
equipment to its workers to prevent
dermal exposure where there is
potential for dermal exposure.
3. Use of a NIOSH-certified respirator
with an APF of at least 50 where there
is a potential for inhalation exposures.
4. Establishment and use of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
5. Not manufacture or process the
PMN substances other than at facilities
equipped with pollution controls, such
as a bag house, that remove particulates
from the air at 99% or greater efficiency.
6. Not use the PMN substances other
than as described in the PMN.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the health effects of the PMN
substances may be potentially useful to
characterize the effects of the PMN
substances in support of a request by the
PMN submitter to modify the Order, or
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that would be
designated by this SNUR. The submitter
has agreed not to exceed the time limits
in the Order without sampling and
analyzing the immediate precursor used
to manufacture the PMN substances via
EPA Method 6010B for the following
elements: arsenic, barium, beryllium,
cadmium, chromium, cobalt, copper,
lead, manganese, mercury, nickel,
selenium, silver, vanadium, and zinc.
CFR citations: 40 CFR 721.11174.
PMN Number: P–16–307
Chemical Name:
Heteropolycycliccarboxylic acid, 1,3dihydro-disubstituted-, polymer with
1,1’-methylenebis, reaction products
with silica (generic).
CAS Number: Not available.
Effective date of TSCA section 5(e)
Order: January 5, 2018.
Basis for TSCA section 5(e) Order:
The PMN states that the generic (non-
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
confidential) use of the substance will
be an open, non-dispersive use. Based
on physical/chemical properties of the
PMN substance and structure activity
relationship (SAR) analysis of test data
on analogous poorly, soluble respirable
particles and isocyanates, EPA
identified concerns for lung effects and
dermal and respiratory sensitization.
The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and
5(e)(l)(A)(ii)(I) of TSCA, based on a
finding that in the absence of sufficient
information to permit a reasoned
evaluation, the substance may present
an unreasonable risk of injury to human
health. To protect against these risks,
the Order requires:
1. Manufacture of the PMN substance
to contain no more than 0.1% residual
of free isocyanate by weight;
2. Use of personal protective
equipment where there is a potential for
dermal exposure;
3. No manufacturing, processing, or
use of the PMN substance in any
manner that generates a vapor, dust,
mist, or aerosol;
4. Refraining from manufacture,
processing or use for consumer use or in
commercial use where there is use in a
consumer setting;
5. Manufacture, process, or use the
PMN substance only in liquid
formulation; and
6. Establishment and use of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about health effects of the PMN
substance may be potentially useful to
characterize the effects of the PMN
substance in support of a request by the
PMN submitter to modify the Order, or
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that would be
designated by this SNUR. EPA has also
determined that the results of acute
toxicity testing and specific target organ
toxicity testing would help characterize
the potential human effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or relevant
information.
CFR citation: 40 CFR 721.11175.
PMN Number: P–17–176
Chemical name: Carbonic acid, alkyl
carbomonocyclic ester (generic).
CAS number: Not available.
PO 00000
Frm 00037
Fmt 4700
Sfmt 4700
50841
Effective date of TSCA section 5(e)
Order: February 21, 2018.
Basis for TSCA section 5(e) Order:
The PMNs state that the generic (nonconfidential) use of the substance will
be as a battery ingredient. Based on
toxicology data from an analogue, EPA
has identified possible human health
concerns for developmental toxicity and
effects on the ovaries, adrenals and
liver. The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health. To
protect against these risk, the Order
requires:
1. Submit to EPA certain toxicity
testing within 3 years of the notice of
commencement of manufacturing
(including import) of the PMN
substance;
2. Use of personal protective
equipment to its workers to prevent
dermal exposure where there is a
potential for dermal exposure;
3. Establishment and use of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
4. Refraining from domestic
manufacture in the United States (i.e.,
import only); and
5. No release of the PMN substance
into waters of the United States
exceeding 45 parts per billion.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the environmental and health
effects of the PMN substance may be
potentially useful to characterize the
effects of the PMN substance in support
of a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that
would be designated by this SNUR. The
submitter has agreed not to manufacture
the PMN substance without performing
specific reproductive/developmental
toxicity testing 3 years from the notice
of commencement. EPA has also
determined that the results of specific
chronic aquatic toxicity testing would
help characterize the potential
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or relevant
information.
CFR citation: 40 CFR 721.11176.
PMN Number: P–17–183.
E:\FR\FM\10OCR1.SGM
10OCR1
daltland on DSKBBV9HB2PROD with RULES
50842
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
Chemical name: 1,3-Propanediol, 2ethyl-2-(hydroxymethyl)-, polymer with
2-(chloromethyl)oxirane, reaction
products with polyethylenepolypropylene glycol 2-aminopropyl Me
ether.
CAS number: 1627528–04–4.
Effective date of TSCA section 5(e)
Order: February 28, 2018.
Basis for TSCA section 5(e) Order:
The PMNs state that the generic (nonconfidential) use of the substance will
be as a pigment wetting and dispersing
additive. Based on the surfactant
potential of the PMN compound, EPA
has identified concerns for lung effects
to workers if respirable particulates or
droplets are inhaled. The Order was
issued under TSCA sections 5(a)(3)(B)(i)
and 5(e)(1)(A)(i), based on a finding that
the available information is insufficient
to permit a reasoned evaluation of the
human health effects of the PMN
substance. To protect against these risks,
the Order requires:
1. Establishment and use of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS;
2. Refraining from domestic
manufacture in the United States (i.e.,
import only);
3. No manufacturing, processing, or
using the PMN substance in any manner
that results in inhalation exposure to
vapors, mists, aerosols or dusts;
4. No use of the PMN substance other
than the confidential uses allowed by
the Order; and
5. No use of the PMN substance in
consumer products.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the health effects of the PMN
substance may be potentially useful to
characterize the effects of the PMN
substance in support of a request by the
PMN submitter to modify the Order, or
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that would be
designated by this SNUR. EPA has
determined that the results of specific
physical-chemical properties and acute
and chronic pulmonary toxicity testing
would help characterize the potential
health effects of the PMN substance.
Although the Order does not require
these tests, the Order’s restrictions
remain in effect until the Order is
modified or revoked by EPA based on
submission of this or relevant
information.
CFR citation: 40 CFR 721.11177.
PMN Number: P–17–232.
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
Chemical name: Copolyamide of an
aromatic dicarboxylic acid and a
mixture of diamines (generic).
CAS number: Not available.
Effective date of TSCA section 5(e)
Order: March 5, 2018.
Basis for TSCA section 5(e) Order:
The PMN states that the generic (nonconfidential) use of the substance is as
an engineering thermoplastic. Based on
SAR analysis on structurally similar
poorly soluble particles, EPA identified
concerns for lung effects to workers if
respirable particles are present. The
Order was issued under TSCA section
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health. To protect against these
risk, the Order requires:
Manufacture the PMN substance with
a particle size of greater than 10
microns.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the health effects of the PMN
substance may be potentially useful to
characterize the effects of the PMN
substance in support of a request by the
PMN submitter to modify the Order, or
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that would be
designated by this SNUR. EPA has also
determined that the results of
pulmonary toxicity testing would help
characterize the potential human effects
of the PMN substance. Although the
Order does not require this testing, the
Order’s restrictions remain in effect
until the Order is modified or revoked
by EPA based on submission of this or
relevant information.
CFR citation: 40 CFR 721.11178.
PMN Number: P–17–257.
Chemical name: Single-walled carbon
nanotubes.
CAS number: Not available.
Effective date of TSCA section 5(e)
Order: January 17, 2018.
Basis for TSCA section 5(e) Order:
The PMN states that the generic (nonconfidential) use of the substance will
be as an additive in composite materials
for mechanical, thermal, and
conductivity improvements. Based on
analysis of analogous carbon nanotubes,
EPA identified concerns for pulmonary
toxicity. Based on analogous carbon
nanotubes, EPA also identified potential
toxicity to aquatic organisms if the PMN
substance is released to water. The order
was issued under TSCA sections
5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I) based
PO 00000
Frm 00038
Fmt 4700
Sfmt 4700
on a finding that in the absence of
sufficient information to permit a
reasoned evaluation, the PMN substance
may present an unreasonable risk of
injury to human health and the
environment. To protect against these
risks, the Order requires:
1. Submit to EPA certain toxicity
testing before manufacturing (including
import) by the times specified in the
Order.
2. Provide personal protective
equipment to its workers to prevent
dermal exposure where there is a
potential for dermal exposure.
3. Provide NIOSH certified respirators
with an APF of at least 50 to its workers
to prevent inhalation exposure.
4. No use of the PMN substance in
application methods that generate a
dust, vapor, mist or aerosol.
5. Use the PMN substance for
industrial uses only.
6. Use the PMN substance only for the
confidential uses allowed in the Order.
7. No release of the PMN substance to
water.
8. Disposal of the PMN substance only
via landfill or incineration.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the environmental and health
effects of the PMN substance may be
potentially useful to characterize the
effects of the PMN substance in support
of a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that
would be designated by this SNUR. The
submitter has agreed not to manufacture
the PMN substance without performing
specific physical property and
pulmonary toxicity testing. EPA has also
determined that the results of specific
chronic aquatic toxicity testing would
help characterize the potential
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or relevant
information.
CFR citation: 40 CFR 721.11179.
PMN Number: P–17–283.
Chemical name: Arenesulfonic acid,
alkyl derivatives, metal salts (generic).
CAS number: Not available.
Effective date of TSCA section 5(e)
Order: February 6, 2018.
Basis for TSCA section 5(e) Order:
The PMN states that the generic (nonconfidential) use of the substance will
be as a lubricating oil additive for
automotive engine oils. Based on
E:\FR\FM\10OCR1.SGM
10OCR1
daltland on DSKBBV9HB2PROD with RULES
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
analysis of test data on the PMN
substance, EPA identified concern for
corrosion to skin, eyes, mucous
membranes, and lungs. There is also
concern for surfactant effects on the
lung based on surfactant properties of
the compounds. There is also concern
for acute toxicity, mutagenicity,
irritation, and sensitization based on
submitted analogue test data. The Order
was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. The
Order was also issued under TSCA
sections 5(a)(3)(B)(ii)(II) and
5(e)(1)(A)(ii)(II), based on a finding that
the substance is or will be produced in
substantial quantities and that the
substance wither enters or may
reasonably be anticipated to enter the
environment in substantial quantities,
or there is or may be significant (or
substantial) human exposure to the
substance. To protect against these risks,
the Order requires:
1. Submit to EPA certain toxicity
testing within six months of filing a
notice of commencement (NOC) to EPA;
2. Use of personal protective
equipment where there is a potential for
dermal exposure;
3. Establishment and use of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS; and
4. Refrain from manufacturing,
processing, or using the PMN substance
in any manner that produces vapor,
mist, spray or aerosol.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the health effects of the PMN
substance may be potentially useful to
characterize the effects of the PMN
substance in support of a request by the
PMN submitter to modify the Order, or
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that would be
designated by this SNUR. The submitter
has agreed not to manufacture the PMN
substance without performing
sensitization testing. EPA has also
determined that the results of specific
physical-chemical properties and acute
and chronic pulmonary toxicity testing
would help characterize the potential
health effects of the PMN substance.
Although the Order does not require
these tests, the Order’s restrictions
remain in effect until the Order is
modified or revoked by EPA based on
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
submission of this or relevant
information.
CFR citation: 40 CFR 721.11180.
PMN Number: P–17–353.
Chemical name: Heteromonocycle, 2[(bicarbomonocycle-2-substituted)alkyl](generic).
CAS number: Not available.
Effective date of TSCA section 5(e)
Order: February 26, 2018.
Basis for TSCA section 5(e) Order:
The PMN states that the generic (nonconfidential) use of the substance will
be as an additive in resin manufacture.
Based on information on analogous
substances, EPA has identified concerns
for irritation to the eye, lung, and
mucous membranes, skin and lung
sensitization, oncogenicity,
developmental toxicity, male
reproductive toxicity, liver toxicity, and
kidney toxicity. Ecotoxicity hazard
concerns were high based on EcoSAR
analysis of analogous chemical. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the PMN substance
may present an unreasonable risk of
injury to human health and the
environment. To protect against these
risks, the Order requires:
1. Refraining from domestic
manufacture in the United States (i.e.,
import only);
2. Use of the PMN substance only for
the confidential use allowed in the
Order;
3. No processing and use of the PMN
substance using methods that may
generate a spray, mist or aerosol.
4. Use of personal protective
equipment where there is a potential for
dermal exposure.
5. Establishment and use of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
6. No release of the PMN substance
into the waters of the United States.
The SNUR designates as a ‘‘significant
new use’’ the absence of these protective
measures.
Potentially useful information: EPA
has determined that certain information
about the environmental and health
effects of the PMN substance may be
potentially useful to characterize the
effects of the PMN substance in support
of a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that
would be designated by this SNUR. EPA
has also determined that the results of
specific acute and chronic aquatic
toxicity testing, skin sensitization
testing, carcinogenicity testing, and
PO 00000
Frm 00039
Fmt 4700
Sfmt 4700
50843
specific target organ testing would help
characterize the potential human effects
of the PMN substance. Although the
Order does not require these tests, the
Order’s restrictions remain in effect
until the Order is modified or revoked
by EPA based on submission of this or
relevant information.
CFR citation: 40 CFR 721.11181.
V. Rationale and Objectives of the Rule
A. Rationale
During review of the PMNs submitted
for the chemical substances that are
subject to these SNURs, EPA concluded
that for all 28 chemical substances,
regulation was warranted under TSCA
section 5(e), pending the development
of information sufficient to make
reasoned evaluations of the health or
environmental effects of the chemical
substances. The basis for such findings
is outlined in Unit IV. Based on these
findings, TSCA section 5(e) Orders
requiring the use of appropriate
exposure controls were negotiated with
the PMN submitters.
The SNURs identify as significant
new uses any manufacturing,
processing, use, distribution in
commerce, or disposal that does not
conform to the restrictions imposed by
the underlying Orders, consistent with
TSCA section 5(f)(4).
B. Objectives
EPA is issuing these SNURs for
specific chemical substances which
have undergone premanufacture review
because the Agency wants to achieve
the following objectives with regard to
the significant new uses designated in
this rule:
• EPA will receive notice of any
person’s intent to manufacture or
process a listed chemical substance for
the described significant new use before
that activity begins.
• EPA will have an opportunity to
review and evaluate data submitted in a
SNUN before the notice submitter
begins manufacturing or processing a
listed chemical substance for the
described significant new use.
• EPA will be able to either determine
that the prospective manufacture or
processing is not likely to present an
unreasonable risk, or to take necessary
regulatory action associated with any
other determination, before the
described significant new use of the
chemical substance occurs.
• EPA will identify as significant new
uses any manufacturing, processing,
use, distribution in commerce, use, or
disposal that does not conform to the
restrictions imposed by the underlying
Orders, consistent with TSCA section
5(f)(4).
E:\FR\FM\10OCR1.SGM
10OCR1
50844
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
Issuance of a SNUR for a chemical
substance does not signify that the
chemical substance is listed on the
TSCA Chemical Substance Inventory
(TSCA Inventory). Guidance on how to
determine if a chemical substance is on
the TSCA Inventory is available on the
internet at https://www.epa.gov/opptintr/
existingchemicals/pubs/tscainventory/
index.html.
daltland on DSKBBV9HB2PROD with RULES
VI. Direct Final Procedures
EPA is issuing these SNURs as a
direct final rule. The effective date of
this rule is December 10, 2018without
further notice, unless EPA receives
written adverse comments before
November 9, 2018.
If EPA receives written adverse
comments on one or more of these
SNURs before November 9, 2018, EPA
will withdraw the relevant sections of
this direct final rule before its effective
date.
This rule establishes SNURs for a
number of chemical substances. Any
person who submits adverse comments
must identify the chemical substance
and the new use to which it applies.
EPA will not withdraw a SNUR for a
chemical substance not identified in the
comment.
VII. Applicability of the Significant
New Use Designation
To establish a significant new use,
EPA must determine that the use is not
ongoing. The chemical substances
subject to this rule have undergone
premanufacture review. In cases where
EPA has not received an NOC and the
chemical substance has not been added
to the TSCA Inventory, no person may
commence such activities without first
submitting a PMN. Therefore, for
chemical substances for which an NOC
has not been submitted EPA concludes
that the designated significant new uses
are not ongoing.
When chemical substances identified
in this rule are added to the TSCA
Inventory, EPA recognizes that, before
the rule is effective, other persons might
engage in a use that has been identified
as a significant new use. However,
TSCA section 5(e) Orders have been
issued for all of the chemical
substances, and the PMN submitters are
prohibited by the TSCA section 5(e)
Orders from undertaking activities
which will be designated as significant
new uses. The identities of 26 of the 28
chemical substances subject to this rule
have been claimed as confidential and
EPA has received no post-PMN bona
fide submissions (per §§ 720.25 and
721.11) for a chemical substance
covered by this action. Based on this,
the Agency believes that it is highly
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
unlikely that any of the significant new
uses described in the regulatory text of
this rule are ongoing.
Therefore, EPA designates October 10,
2018 as the cutoff date for determining
whether the new use is ongoing. The
objective of EPA’s approach has been to
ensure that a person could not defeat a
SNUR by initiating a significant new use
before the effective date of the direct
final rule.
Persons who begin commercial
manufacture or processing of the
chemical substances for a significant
new use identified as of that date will
have to cease any such activity upon the
effective date of the final rule. To
resume their activities, these persons
will have to first comply with all
applicable SNUR notification
requirements and wait until EPA has
conducted a review of the notice, made
an appropriate determination on the
notice, and has taken such actions as are
required with that determination.
VIII. Development and Submission of
Information
EPA recognizes that TSCA section 5
does not require developing any
particular new information (e.g.,
generating test data) before submission
of a SNUN. There is an exception:
Development of test data is required
where the chemical substance subject to
the SNUR is also subject to a rule, order
or consent agreement under TSCA
section 4 (see TSCA section 5(b)(1)).
In the absence of a TSCA section 4
test rule covering the chemical
substance, persons are required only to
submit information in their possession
or control and to describe any other
information known to or reasonably
ascertainable by them (see 40 CFR
720.50). However, upon review of PMNs
and SNUNs, the Agency has the
authority to require appropriate testing.
Unit IV. lists potentially useful
information for all of the listed SNURs.
Descriptions of the information are
provided for informational purposes.
EPA strongly encourages persons, before
performing any testing, to consult with
the Agency pertaining to protocol
selection. Furthermore, pursuant to
TSCA section 4(h), which pertains to
reduction of testing in vertebrate
animals, EPA encourages consultation
with the Agency on the use of
alternative test methods and strategies
(also called New Approach
Methodologies, or NAMs), if available,
to generate the recommended test data.
EPA encourages dialog with Agency
representatives to help determine how
best the submitter can meet both the
data needs and the objective of TSCA
section 4(h).
PO 00000
Frm 00040
Fmt 4700
Sfmt 4700
In certain of the TSCA section 5(e)
Orders for the chemical substances
regulated under this rule, EPA has
established production volume or time
limits in view of the lack of data on the
potential health and environmental
risks that may be posed by the
significant new uses or increased
exposure to the chemical substances.
These limits cannot be exceeded unless
the PMN submitter first submits the
results of toxicity tests that would
permit a reasoned evaluation of the
potential risks posed by these chemical
substances. Listings of the information
required in the TSCA section 5(e)
Orders are included in Unit IV. The
SNURs contain the same production
volume limits as the TSCA section 5(e)
Orders. Exceeding these production
limits is defined as a significant new
use. Persons who intend to exceed the
production limit must notify the Agency
by submitting a SNUN at least 90 days
in advance of commencement of nonexempt commercial manufacture or
processing.
Any request by EPA for the triggered
and pended testing described in the
Orders was made based on EPA’s
consideration of available screeninglevel data, if any, as well as other
available information on appropriate
testing for the PMN substances. Further,
any such testing request on the part of
EPA that includes testing on vertebrates
was made after consideration of
available toxicity information,
computational toxicology and
bioinformatics, and high-throughput
screening methods and their prediction
models.
Potentially useful information
identified in Unit IV. may not be the
only means of addressing the potential
risks of the chemical substance.
However, submitting a SNUN without
any test data may increase the
likelihood that EPA will take action
under TSCA section 5(e), particularly if
satisfactory test results have not been
obtained from a prior PMN or SNUN
submitter. EPA recommends that
potential SNUN submitters contact EPA
early enough so that they will be able
to conduct the appropriate tests.
SNUN submitters should be aware
that EPA will be better able to evaluate
SNUNs which provide detailed
information on the following:
• Human exposure and
environmental release that may result
from the significant new use of the
chemical substances.
• Information on risks posed by the
chemical substances compared to risks
posed by potential substitutes.
E:\FR\FM\10OCR1.SGM
10OCR1
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
IX. Procedural Determinations
By this rule, EPA is establishing
certain significant new uses which have
been claimed as CBI subject to Agency
confidentiality regulations at 40 CFR
part 2 and 40 CFR part 720, subpart E.
Absent a final determination or other
disposition of the confidentiality claim
under 40 CFR part 2 procedures, EPA is
required to keep this information
confidential. EPA promulgated a
procedure to deal with the situation
where a specific significant new use is
CBI, at § 721.1725(b)(1).
Under these procedures a
manufacturer or processor may request
EPA to determine whether a proposed
use would be a significant new use
under the rule. The manufacturer or
processor must show that it has a bona
fide intent to manufacture or process the
chemical substance and must identify
the specific use for which it intends to
manufacture or process the chemical
substance. If EPA concludes that the
person has shown a bona fide intent to
manufacture or process the chemical
substance, EPA will tell the person
whether the use identified in the bona
fide submission would be a significant
new use under the rule. Since most of
the chemical identities of the chemical
substances subject to these SNURs are
also CBI, manufacturers and processors
can combine the bona fide submission
under the procedure in § 721.1725(b)(1)
with that under § 721.11 into a single
step.
If EPA determines that the use
identified in the bona fide submission
would not be a significant new use, i.e.,
the use does not meet the criteria
specified in the rule for a significant
new use, that person can manufacture or
process the chemical substance so long
as the significant new use trigger is not
met. In the case of a production volume
trigger, this means that the aggregate
annual production volume does not
exceed that identified in the bona fide
submission to EPA. Because of
confidentiality concerns, EPA does not
typically disclose the actual production
volume that constitutes the use trigger.
Thus, if the person later intends to
exceed that volume, a new bona fide
submission would be necessary to
determine whether that higher volume
would be a significant new use.
daltland on DSKBBV9HB2PROD with RULES
X. SNUN Submissions
According to § 721.1(c), persons
submitting a SNUN must comply with
the same notification requirements and
EPA regulatory procedures as persons
submitting a PMN, including
submission of test data on health and
environmental effects as described in 40
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
CFR 720.50. SNUNs must be submitted
on EPA Form No. 7710–25, generated
using e-PMN software, and submitted to
the Agency in accordance with the
procedures set forth in 40 CFR 720.40
and 721.25. E–PMN software is
available electronically at https://
www.epa.gov/opptintr/newchems.
XI. Economic Analysis
EPA has evaluated the potential costs
of establishing SNUN requirements for
potential manufacturers and processors
of the chemical substances subject to
this rule. EPA’s complete economic
analysis is available in the docket under
docket ID number EPA–HQ–OPPT–
2018–0649.
XII. Statutory and Executive Order
Reviews
A. Executive Order 12866
This action establishes SNURs for
several new chemical substances that
were the subject of PMNs, or TSCA
section 5(e) Orders. The Office of
Management and Budget (OMB) has
exempted these types of actions from
review under Executive Order 12866,
entitled ‘‘Regulatory Planning and
Review’’ (58 FR 51735, October 4, 1993).
B. Paperwork Reduction Act (PRA)
According to PRA (44 U.S.C. 3501 et
seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to a collection of information
that requires OMB approval under PRA,
unless it has been approved by OMB
and displays a currently valid OMB
control number. The OMB control
numbers for EPA’s regulations in title 40
of the CFR, after appearing in the
Federal Register, are listed in 40 CFR
part 9, and included on the related
collection instrument or form, if
applicable. EPA is amending the table in
40 CFR part 9 to list the OMB approval
number for the information collection
requirements contained in this action.
This listing of the OMB control numbers
and their subsequent codification in the
CFR satisfies the display requirements
of PRA and OMB’s implementing
regulations at 5 CFR part 1320. This
Information Collection Request (ICR)
was previously subject to public notice
and comment prior to OMB approval,
and given the technical nature of the
table, EPA finds that further notice and
comment to amend it is unnecessary. As
a result, EPA finds that there is ‘‘good
cause’’ under section 553(b)(3)(B) of the
Administrative Procedure Act (5 U.S.C.
553(b)(3)(B)) to amend this table
without further notice and comment.
The information collection
requirements related to this action have
PO 00000
Frm 00041
Fmt 4700
Sfmt 4700
50845
already been approved by OMB
pursuant to PRA under OMB control
number 2070–0012 (EPA ICR No. 574).
This action does not impose any burden
requiring additional OMB approval. If
an entity were to submit a SNUN to the
Agency, the annual burden is estimated
to average between 30 and 170 hours
per response. This burden estimate
includes the time needed to review
instructions, search existing data
sources, gather and maintain the data
needed, and complete, review, and
submit the required SNUN.
Send any comments about the
accuracy of the burden estimate, and
any suggested methods for minimizing
respondent burden, including through
the use of automated collection
techniques, to the Director, Collection
Strategies Division, Office of
Environmental Information (2822T),
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460–0001. Please remember to
include the OMB control number in any
correspondence, but do not submit any
completed forms to this address.
C. Regulatory Flexibility Act (RFA)
On February 18, 2012, EPA certified
pursuant to RFA section 605(b) (5 U.S.C.
601 et seq.), that promulgation of a
SNUR does not have a significant
economic impact on a substantial
number of small entities where the
following are true:
1. A significant number of SNUNs
would not be submitted by small
entities in response to the SNUR.
2. The SNUR submitted by any small
entity would not cost significantly more
than $8,300. A copy of that certification
is available in the docket for this action.
This action is within the scope of the
February 18, 2012 certification. Based
on the Economic Analysis discussed in
Unit XI. and EPA’s experience
promulgating SNURs (discussed in the
certification), EPA believes that the
following are true:
• A significant number of SNUNs
would not be submitted by small
entities in response to the SNUR.
• Submission of the SNUN would not
cost any small entity significantly more
than $8,300.
Therefore, the promulgation of the
SNUR would not have a significant
economic impact on a substantial
number of small entities.
D. Unfunded Mandates Reform Act
(UMRA)
Based on EPA’s experience with
proposing and finalizing SNURs, State,
local, and Tribal governments have not
been impacted by these rulemakings,
and EPA does not have any reasons to
E:\FR\FM\10OCR1.SGM
10OCR1
50846
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
believe that any State, local, or Tribal
government will be impacted by this
action. As such, EPA has determined
that this action does not impose any
enforceable duty, contain any unfunded
mandate, or otherwise have any effect
on small governments subject to the
requirements of UMRA sections 202,
203, 204, or 205 (2 U.S.C. 1501 et seq.).
E. Executive Order 13132
This action will not have a substantial
direct effect on States, on the
relationship between the national
government and the States, or on the
distribution of power and
responsibilities among the various
levels of government, as specified in
Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999).
F. Executive Order 13175
This action does not have Tribal
implications because it is not expected
to have substantial direct effects on
Indian Tribes. This action does not
significantly nor uniquely affect the
communities of Indian Tribal
governments, nor does it involve or
impose any requirements that affect
Indian Tribes. Accordingly, the
requirements of Executive Order 13175,
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000), do not apply
to this action.
G. Executive Order 13045
This action is not subject to Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997), because this is not an
economically significant regulatory
action as defined by Executive Order
12866, and this action does not address
environmental health or safety risks
disproportionately affecting children.
H. Executive Order 13211
daltland on DSKBBV9HB2PROD with RULES
This action is not subject to Executive
Order 13211, entitled ‘‘Actions
Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use’’ (66 FR 28355, May
22, 2001), because this action is not
expected to affect energy supply,
distribution, or use and because this
action is not a significant regulatory
action under Executive Order 12866.
I. National Technology Transfer and
Advancement Act (NTTAA)
In addition, since this action does not
involve any technical standards,
NTTAA section 12(d) (15 U.S.C. 272
note), does not apply to this action.
VerDate Sep<11>2014
18:18 Oct 09, 2018
Jkt 247001
J. Executive Order 12898
OMB control
No.
40 CFR citation
This action does not entail special
considerations of environmental justice
related issues as delineated by
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
XIII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
*
*
*
*
*
Significant New Uses of Chemical
Substances
*
721.11173
721.11174
721.11175
721.11176
721.11177
721.11178
721.11179
721.11180
721.11181
*
*
*
*
.............................
.............................
.............................
.............................
.............................
.............................
.............................
.............................
.............................
*
*
*
*
*
*
*
2070–0012
2070–0012
2070–0012
2070–0012
2070–0012
2070–0012
2070–0012
2070–0012
2070–0012
*
*
*
PART 721—[AMENDED]
List of Subjects
3. The authority citation for part 721
continues to read as follows:
■
40 CFR Part 9
Environmental protection, Reporting
and recordkeeping requirements.
Authority: 15 U.S.C. 2604, 2607, and
2625(c).
40 CFR Part 721
■
Environmental protection, Chemicals,
Hazardous substances, Reporting and
recordkeeping requirements.
§ 721.11173 Rare earth doped zirconium
oxide (generic).
Dated: October 1, 2018.
Jeffery T. Morris,
Director, Office of Pollution Prevention and
Toxics.
Therefore, 40 CFR parts 9 and 721 are
amended as follows:
PART 9—[AMENDED]
1. The authority citation for part 9
continues to read as follows:
■
Authority: 7 U.S.C. 135 et seq., 136–136y;
15 U.S.C. 2001, 2003, 2005, 2006, 2601–2671;
21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33
U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318,
1321, 1326, 1330, 1342, 1344, 1345 (d) and
(e), 1361; E.O. 11735, 38 FR 21243, 3 CFR,
1971–1975 Comp. p. 973; 42 U.S.C. 241,
242b, 243, 246, 300f, 300g, 300g–1, 300g–2,
300g–3, 300g–4, 300g–5, 300g–6, 300j–1,
300j–2, 300j–3, 300j–4, 300j–9, 1857 et seq.,
6901–6992k, 7401–7671q, 7542, 9601–9657,
11023, 11048.
2. In § 9.1, add the following sections
in numerical order under the
undesignated center heading
‘‘Significant New Uses of Chemical
Substances’’ to read as follows:
■
§ 9.1 OMB approvals under the Paperwork
Reduction Act.
*
PO 00000
*
*
Frm 00042
*
Fmt 4700
*
Sfmt 4700
4. Add § 721.11173 to subpart E to
read as follows:
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substances identified
generically as rare earth doped
zirconium oxide (P–15–442, P–15–443,
P–15–444, P–15–445, P–15–446, P–15–
447, P–15–525, P–15–526, P–15–527,
and P–15–528) are subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been reacted
(cured).
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(4), (when determining which
persons are reasonably likely to be
exposed as required for § 721.63(a)(4),
engineering control measures (e.g.,
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible), (a)(5)
(respirators must provide a National
Institute for Occupational Safety and
Health (NIOSH) assigned protection
factor of at least 1000), (a)(6)
(particulate), (b) (concentration set at
1.0%), and (c).
E:\FR\FM\10OCR1.SGM
10OCR1
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
(A) As an alternative to the respirator
requirements in paragraph (a)(2)(i) of
this section, a manufacturer or processor
may choose to follow the new chemical
exposure limit (NCEL) provision listed
in the TSCA section 5(e) Order for this
substance. The NCEL is 0.07 mg/m3 as
an 8-hour time weighted average.
Persons who wish to pursue NCELs as
an alternative to § 721.63 respirator
requirements may request to do so
under § 721.30. Persons whose § 721.30
requests to use the NCELs approach are
approved by EPA will be required to
follow NCELs provisions comparable to
those contained in the corresponding
TSCA section 5(e) Order.
(B) [Reserved]
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (e)(concentration set at 1.0%),
(f), (g)(1)(ii), (g)(2)(ii), (iii), (iv)(use
respiratory protection or maintain
workplace airborne concentrations at or
below an 8-hour time-weighted average
of 0.07 mg/m3), and (g)(5). Alternative
hazard and warning statements that
meet the criteria of the Globally
Harmonized System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(p) (18 months).
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (d) and (f) through
(i) are applicable to manufacturers and
processors of the substances.
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
■ 5. Add § 721.11174 to subpart E to
read as follows:
daltland on DSKBBV9HB2PROD with RULES
§ 721.11174
(generic).
Silane-treated aluminosilicate
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substances identified
generically as silane-treated
aluminosilicate (PMNs P–16–194, P–16–
195, P–16–196, P–16–197, P–16–198, P–
16–199, P–16–460, P–16–461, P–16–
462, P–16–463, and P–16–464) are
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substances
after they have been completely
incorporated into a polymer matrix.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
§ 721.63(a)(4), (when determining which
persons are reasonably likely to be
exposed as required for § 721.63(a)(4),
engineering control measures (e.g.
enclosure or confinement of operation,
general and local ventilation) or
administrative control measures (e.g.
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible), (a)(5)
(respirators must provide a National
Institute for Occupational Safety and
Health assigned protection factor of at
least 50), (a)(6) (particulate), (b)
(concentration set at 0.1%), and (c).
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (e) (concentration set at 0.1%),
(f), (g)(1)(ii), (iii), (iv), (v), (vi), (vii),
(viii), (ix), (g)(2)(i), (ii), (iii), (iv), (v), and
(g)(5). Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80. It is a significant
new use to manufacture the substances
without sampling and analyzing the
immediate precursor used to
manufacture the substances according to
the terms specified in the 5(e) Order for
the following elements: Arsenic,
barium, beryllium, cadmium,
chromium, cobalt, copper, lead,
manganese, mercury, nickel, selenium,
silver, vanadium, and zinc. It is a
significant new use to manufacture the
substances at facilities other than those
equipped with pollution controls, such
as a bag house, that remove particulates
from the air at 99% or greater efficiency.
It is a significant new use to process the
substances other than in an enclosed
system that does not allow for the
release of particulates or at facilities
equipped with pollution controls, such
as a bag house, that remove particulates
from the air at 99% or greater efficiency.
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (d), (f), (g), (h), and
(i) are applicable to manufacturers and
processors of this substance.
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
(3) Determining whether a specific use
is subject to this section. The provisions
of § 721.1725(b)(1) apply to paragraph
(a)(2)(iii) of this section.
■ 6. Add § 721.11175 to subpart E to
read as follows:
PO 00000
Frm 00043
Fmt 4700
Sfmt 4700
50847
§ 721.11175 Heteropolycycliccarboxylic
acid, 1,3-dihydro-disubstituted-, polymer
with 1,1’-methylenebis, reaction products
with silica (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance generically
identified as heteropolycycliccarboxylic
acid, 1,3-dihydro-disubstituted-,
polymer with 1,1’-methylenebis,
reaction products with silica (P–16–307)
is subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been reacted (cured).
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (a)(2)(i), (ii), (iii), (a)(3),
(a)(6) (particulate), (when determining
which persons are reasonably likely to
be exposed as required for
§ 721.63(a)(1), engineering control
measures (e.g. enclosure or confinement
of the operation, general and local
ventilation) or administrative control
measures (e.g. workplace policies and
procedures) shall be considered and
implemented to prevent exposures,
where feasible), (b) (concentration set at
1.0%), and (c).
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (e) (concentration set at 1.0%),
(f), (g)(1)(i), (ii), (g)(2)(i), (ii), (iii), (v),
and (g)(5). Alternative hazard and
warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80. It is a significant
new use to manufacture, process, or use
the substance for consumer use or for
commercial uses that could introduce
the substance into a consumer setting. It
is a significant new use to manufacture,
process, or use the substance other than
in a liquid formulation. It is a significant
new use to manufacture the PMN
substance to contain more than 0.1%
residual isocyanate by weight. It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in generation of a
vapor, dust, mist or aerosol.
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
E:\FR\FM\10OCR1.SGM
10OCR1
50848
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.11177 1,3-Propanediol, 2-ethyl-2(hydroxymethyl)-, polymer with 2(chloromethyl)oxirane, reaction products
with polyethylene-polypropylene glycol 2aminopropyl Me ether.
7. Add § 721.11176 to subpart E to
read as follows:
(a) Chemical substance and
significant new used subject to
reporting. (1) The chemical substance
identified as 1,3-propanediol, 2-ethyl-2(hydroxymethyl)-, polymer with
2-(chloromethyl)oxirane, reaction
products with polyethylenepolypropylene glycol 2-aminopropyl Me
ether (PMN P–17–183, CAS No
1627528–04–4) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been reacted
(cured).
(2) The significant new uses are:
(i) Hazard communication.
Requirements as specified in § 721.72(a)
through (e) (concentration set at 1.0%),
(f), (g)(1)(ii), (g)(2)(ii), and (g)(5).
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(ii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), (o). It is a
significant new use to process or use the
substance in any manner way that
results in generation of a vapor, dust,
mist or aerosol.
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a), (b), (c), (f) through (i) are
applicable to manufacturers and
processors of this substance.
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
■ 9. Add § 721.11178 to subpart E to
read as follows:
■
daltland on DSKBBV9HB2PROD with RULES
§ 721.11176 Carbonic acid, alkyl
carbomonocyclic ester (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as carbonic acid, alkyl
carbomonocyclic ester (PMN P–17–176)
is subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (a)(2), (a)(2)(i), (iv), (a)(3),
(a)(6) (particulate), (a)(6)(v), (vi), (when
determining which persons are
reasonable likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g. enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g. workplace
policies and procedures) shall be
considered and implemented to prevent
exposures, where feasible),
(b)(concentration set at 1.0%), and (c).
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (e)(concentration set at 1.0%),
(f), (g)(1)(iv), (v), (vi), (ix), (g)(2)(i), (v),
(g)(3)(i), (ii), (g)(4) (do not release to
water above 45 parts per billion), and
(g)(5). Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f) and (p)(3 years).
(iv) Release to water. Release to water
requirements as specified in
§ 721.90(a)(4), (b)(4), and (c)(4) where N
= 45 ppb.
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), (k).
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
8. Add § 721.11177 to subpart E to
read as follows:
■
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
§ 721.11178 Copolyamide of an aromatic
dicarboxylic acid and a mixture of diamines
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as copolyamide of an
aromatic dicarboxylic acid and a
mixture of diamines (PMN P–17–232) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Industrial, commercial, and
consumer activities. Requirements as
PO 00000
Frm 00044
Fmt 4700
Sfmt 4700
specified in § 721.80. It is a significant
new use to manufacture the substance
with a particle size less than 10
microns.
(ii) [Reserved]
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (c) and (i).
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
■ 10. Add § 721.11179 to subpart E to
read as follows:
§ 721.11179
nanotubes.
Single-walled carbon
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified as
single-walled carbon nanotubes (PMN
P–17–257) is subject to reporting under
this section for the significant new uses
described in paragraph (a)(2) of this
section. The requirements of this section
do not apply to quantities of the
substances that have been:
(i) Embedded or incorporated into a
polymer matrix that itself has been
reacted (cured);
(ii) Embedded in a permanent solid
polymer form that is not intended to
undergo further processing, except
mechanical processing; or
(iii) Incorporated into an article as
defined at 40 CFR 720.3(c).
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (a)(2)(i), (a)(3), (a)(4),
(when determining which persons are
reasonable likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measure (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible),
(a)(5)(respirators must provide a
National Institute for Occupational
Safety and Health assigned protection
factor of at least 50), (a)(6) (particulate),
and (c).
(ii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), (p) (6
months), (y)(1), and (y)(2). (It is a
significant new use to process or use the
substance for non-industrial use except
for the confidential non-industrial use
described in the 5(e) Order).
E:\FR\FM\10OCR1.SGM
10OCR1
Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Rules and Regulations
(iii) Disposal. Requirements as
specified in § 721.85(a)(1), (a)(2), (b)(1),
(b)(2), (c)(1), (c)(2).
(iv) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), (c)(1).
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (e), (j), and (k) are
applicable to manufacturers and
processors of this substance.
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
(3) Determining whether a specific use
is subject to this section. The provisions
of § 721.1725(b)(1) apply to paragraph
(a)(2)(iii) of this section.
■ 11. Add § 721.11180 to subpart E to
read as follows:
daltland on DSKBBV9HB2PROD with RULES
§ 721.11180 Arenesulfonic acid, alkyl
derivatives, metal salts (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as arenesulfonic acid, alkyl
derivatives, metal salts (PMN P–17–283)
is subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (a)(2)(i), (iii), (a)(3),
(when determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g. enclosure or
confinement of operation, general and
local ventilation) or administrative
control measures (e.g. workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible), (b)
(concentration set at 1.0%), and (c).
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (e) (concentration set at 1.0%),
(f), (g)(1)(skin sensitization), (eye
irritation), (lung effects), (skin
corrosion), (g)(2)(i), (iii), (v), and (g)(5).
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(p) (6 months). It is
a significant new use to manufacture,
process or use the substance in any
manner way that results in generation of
a vapor, mist, spray, or aerosol.
VerDate Sep<11>2014
16:31 Oct 09, 2018
Jkt 247001
(b) Specific requirements. The
provisions of subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i).
(2) Limitations or revocation of
certain notification requirements. The
provision of § 721.185 apply to this
section.
■ 12. Add § 721.11181 to subpart E to
read as follows:
§ 721.11181 Heteromonocycle, 2[(bicarbomonocycle-2-substituted)alkyl](generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as heteromonocycle, 2[(bicarbomonocycle-2-substituted)alkyl](PMN P–17–353) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been reacted
(cured).
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (a)(2)(i), (ii), (iii), (iv),
(a)(3), (when determining which
persons are reasonably likely to be
exposed as required for § 721.63(a)(1),
engineering control measures (e.g.
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible), (b)
(concentration set at 0.1%), and (c).
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (e) (concentration set at 0.1%),
(f), (g)(1), (g)(1)(iv), (vi), (vii), (ix),
(mutagenicity), (eye, skin, lung, and
mucous membrane irritation), (skin and
lung sensitization), (g)(2)(i), (ii), (iii), (v),
(avoid workplace airborne
concentrations), (g)(3)(i), (ii), (g)(4)(iii),
and (g)(5). Alternative hazard and
warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities: Requirements as
specified in § 721.80(f) and (k). It is a
significant new use to process or use the
substance in any manner that generates
a vapor, spray, mist, or aerosol.
(iv) Release to water. Requirements as
specified in § 721.90(b)(1) and (c)(1).
(b) Specific requirements. The
provisions of subpart A of this part
PO 00000
Frm 00045
Fmt 4700
Sfmt 4700
50849
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) and (k) are
applicable to manufacturers and
processors of this substance.
(2) Limitations or revocation of
certain notification requirements. The
provisions of § 721.185 apply to this
section.
(3) Determining whether a specific use
is subject to this section. The provisions
of § 721.1725(b)(1) apply to paragraph
(a)(2)(iii) of this section.
[FR Doc. 2018–21871 Filed 10–9–18; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 52
[EPA–R05–OAR–2017–0060; FRL–9985–12–
Region 5]
Air Plan Approval; Minnesota;
Infrastructure SIP Requirements for
the 2012 PM2.5 NAAQS; Multistate
Transport
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
The Environmental Protection
Agency (EPA) is approving elements of
the State Implementation Plan (SIP)
submission from Minnesota regarding
the infrastructure requirements of
section 110 of the Clean Air Act (CAA)
for the 2012 annual fine particulate
matter (PM2.5) National Ambient Air
Quality Standard (NAAQS or standard).
The infrastructure requirements are
designed to ensure that the structural
components of each state’s air quality
management program are adequate to
meet the state’s responsibilities under
the CAA. This action pertains
specifically to infrastructure
requirements concerning interstate
transport provisions.
DATES: This final rule is effective on
November 9, 2018.
ADDRESSES: EPA has established a
docket for this action under Docket ID
No. EPA–R05–OAR–2017–0060. All
documents in the docket are listed on
the www.regulations.gov website.
Although listed in the index, some
information is not publicly available,
i.e., Confidential Business Information
(CBI) or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the internet and will be publicly
available only in hard copy form.
SUMMARY:
E:\FR\FM\10OCR1.SGM
10OCR1
Agencies
[Federal Register Volume 83, Number 196 (Wednesday, October 10, 2018)]
[Rules and Regulations]
[Pages 50838-50849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21871]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Parts 9 and 721
[EPA-HQ-OPPT-2018-0649; FRL-9984-65]
RIN 2070-AB27
Significant New Use Rules on Certain Chemical Substances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Direct final rule.
-----------------------------------------------------------------------
SUMMARY: EPA is promulgating significant new use rules (SNURs) under
the Toxic Substances Control Act (TSCA) for 28 chemical substances
which were the subject of premanufacture notices (PMNs). The chemical
substances are subject to Orders issued by EPA pursuant to section 5(e)
of TSCA. This action requires persons who intend to manufacture
(defined by statute to include import) or process any of these 28
chemical substances for an activity that is designated as a significant
new use by this rule to notify EPA at least 90 days before commencing
that activity. The required notification initiates EPA's evaluation of
the intended use within the applicable review period. Persons may not
commence manufacture or processing for the significant new use until
EPA has conducted a review of the notice, made an appropriate
determination on the notice, and has taken such actions as are required
with that determination.
DATES: This rule is effective on December 10, 2018. For purposes of
judicial review, this rule shall be promulgated at 1 p.m. (e.s.t.) on
October 24, 2018.
Written adverse comments on one or more of these SNURs must be
received on or before November 9, 2018 (see Unit VI. of the
SUPPLEMENTARY INFORMATION). If EPA receives written adverse comments,
on one or more of these SNURs before November 9, 2018, EPA will
withdraw the relevant sections of this direct final rule before its
effective date.
For additional information on related reporting requirement dates,
see Units I.A., VI., and VII. of the SUPPLEMENTARY INFORMATION.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2018-0649, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
Mail: Document Control Office (7407M), Office of Pollution
Prevention and Toxics (OPPT), Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Kenneth Moss, Chemical Control
Division (7405M), Office of Pollution Prevention and Toxics,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number: (202) 564-9232; email address:
[email protected].
For general information contact: The TSCA--Hotline, ABVI-Goodwill,
422 South Clinton Ave. Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected]
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you manufacture,
process, or use the chemical substances contained in this rule. The
following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Manufacturers or processors of one or more subject
chemical substances (NAICS codes 325 and 324110), e.g., chemical
manufacturing and petroleum refineries.
This action may also affect certain entities through pre-existing
import certification and export notification rules under TSCA. Chemical
importers are subject to the TSCA section 13 (15 U.S.C. 2612) import
certification
[[Page 50839]]
requirements promulgated at 19 CFR 12.118 through 12.127 and 19 CFR
127.28. Chemical importers must certify that the shipment of the
chemical substance complies with all applicable rules and orders under
TSCA. Importers of chemicals subject to these SNURs must certify their
compliance with the SNUR requirements. The EPA policy in support of
import certification appears at 40 CFR part 707, subpart B. In
addition, any persons who export or intend to export a chemical
substance that is the subject of this rule on or after November 9, 2018
are subject to the export notification provisions of TSCA section 12(b)
(15 U.S.C. 2611(b)) (see Sec. 721.20), and must comply with the export
notification requirements in 40 CFR part 707, subpart D.
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark part or all of the information
that you claim to be CBI. For CBI information in a disk or CD-ROM that
you mail to EPA, mark the outside of the disk or CD-ROM as CBI and then
identify electronically within the disk or CD-ROM the specific
information that is claimed as CBI. In addition to one complete version
of the comment that includes information claimed as CBI, a copy of the
comment that does not contain the information claimed as CBI must be
submitted for inclusion in the public docket. Information so marked
will not be disclosed except in accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at https://www.epa.gov/dockets/comments.html.
II. Background
A. What action is the agency taking?
1. Direct Final Rule. EPA is promulgating these SNURs using direct
final rule procedures. These SNURs will require persons to notify EPA
at least 90 days before commencing the manufacture or processing of a
chemical substance for any activity designated by these SNURs as a
significant new use. Receipt of such notices obligates EPA to assess
risks that may be associated with the significant new uses under the
conditions of use and, if appropriate, to regulate the proposed uses
before they occur.
2. Proposed Rule. In addition to this Direct Final Rule, elsewhere
in this issue of the Federal Register, EPA is issuing a Notice of
Proposed Rulemaking for this rule. If EPA receives no adverse comment,
the Agency will not take further action on the proposed rule and the
direct final rule will become effective as provided in this action. If
EPA receives adverse comment on one or more of SNURs in this action by
October 25, 2018 (see Unit VI. of the SUPPLEMENTARY INFORMATION), the
Agency will publish in the Federal Register a timely withdrawal of the
specific SNURs that the adverse comments pertain to, informing the
public that the actions will not take effect. EPA would then address
all adverse public comments in a response to comments document in a
subsequent final rule, based on the proposed rule.
B. What is the agency's authority for taking this action?
Section 5(a)(2) of TSCA (15 U.S.C. 2604(a)(2)) authorizes EPA to
determine that a use of a chemical substance is a ``significant new
use.'' EPA must make this determination by rule after considering all
relevant factors, including the four bulleted TSCA section 5(a)(2)
factors listed in Unit III. Once EPA determines that a use of a
chemical substance is a significant new use, TSCA section 5(a)(1)(B)
requires persons to submit a significant new use notice (SNUN) to EPA
at least 90 days before they manufacture or process the chemical
substance for that use (15 U.S.C. 2604(a)(1)(B)(i)). TSCA furthermore
prohibits such manufacturing or processing from commencing until EPA
has conducted a review of the notice, made an appropriate determination
on the notice, and taken such actions as are required in association
with that determination (15 U.S.C. 2604(a)(1)(B)(ii)). As described in
Unit V., the general SNUR provisions are found at 40 CFR part 721,
subpart A.
C. Applicability of General Provisions
General provisions for SNURs appear in 40 CFR part 721, subpart A.
These provisions describe persons subject to the rule, recordkeeping
requirements, exemptions to reporting requirements, and applicability
of the rule to uses occurring before the effective date of the rule.
Provisions relating to user fees appear at 40 CFR part 700. According
to Sec. 721.1(c), persons subject to these SNURs must comply with the
same SNUN requirements and EPA regulatory procedures as submitters of
PMNs under TSCA section 5(a)(1)(A). In particular, these requirements
include the information submission requirements of TSCA section 5(b)
and 5(d)(1), the exemptions authorized by TSCA section 5(h)(1), (h)(2),
(h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once EPA
receives a SNUN, EPA must either determine that the significant new use
is not likely to present an unreasonable risk of injury or take such
regulatory action as is associated with an alternative determination
before the manufacture or processing for the significant new use can
commence. If EPA determines that the significant new use is not likely
to present an unreasonable risk, EPA is required under TSCA section
5(g) to make public, and submit for publication in the Federal
Register, a statement of EPA's findings.
III. Significant New Use Determination
Section 5(a)(2) of TSCA states that EPA's determination that a use
of a chemical substance is a significant new use must be made after
consideration of all relevant factors, including:
The projected volume of manufacturing and processing of a
chemical substance.
The extent to which a use changes the type or form of
exposure of human beings or the environment to a chemical substance.
The extent to which a use increases the magnitude and
duration of exposure of human beings or the environment to a chemical
substance.
The reasonably anticipated manner and methods of
manufacturing, processing, distribution in commerce, and disposal of a
chemical substance.
In addition to these factors enumerated in TSCA section 5(a)(2),
the statute authorizes EPA to consider any other relevant factors.
To determine what would constitute a significant new use for the 28
chemical substances that are the subject of these SNURs, EPA considered
relevant information about the toxicity of the chemical substances,
likely human exposures and environmental releases associated with
possible uses, and the four bulleted TSCA section 5(a)(2) factors
listed in this unit.
IV. Substances Subject to This Rule
EPA is establishing significant new use and recordkeeping
requirements for 28 chemical substances in 40 CFR part 721, subpart E.
In this unit, EPA provides the following information for each chemical
substance:
PMN number.
Chemical name (generic name, if the specific name is
claimed as CBI).
Chemical Abstracts Service (CAS) Registry number (if
assigned for non-confidential chemical identities).
Basis for the TSCA section 5(e) Order.
Information identified by EPA that would help characterize
the potential
[[Page 50840]]
health and/or environmental effects of the chemical substance in
support of a request by the PMN submitter to modify the Order, or if a
manufacturer or processor is considering submitting a SNUN for a
significant new use designated by the SNUR.
This information may include testing required in a TSCA section
5(e) Order to be conducted by the PMN submitter, as well as testing not
required to be conducted but which would also help characterize the
potential health and/or environmental effects of the PMN substance. Any
recommendation for information identified by EPA was made based on
EPA's consideration of available screening-level data, if any, as well
as other available information on appropriate testing for the chemical
substance. Further, any such testing identified by EPA that includes
testing on vertebrates was made after consideration of available
toxicity information, computational toxicology and bioinformatics, and
high-throughput screening methods and their prediction models. EPA also
recognizes that whether testing/further information is needed will
depend on the specific exposure and use scenario in the SNUN. EPA
encourages all SNUN submitters to contact EPA to discuss any potential
future testing. See Unit VIII. for more information.
CFR citation assigned in the regulatory text section of
this rule.
The regulatory text section of these rules specifies the activities
designated as significant new uses. Certain new uses, including
exceedance of production volume limits (i.e., limits on manufacture
volume) and other uses designated in this rule, may be claimed as CBI.
Unit IX. discusses a procedure companies may use to ascertain whether a
proposed use constitutes a significant new use.
These rules include 28 PMN substances that are subject to Orders
under TSCA section 5(e)(1)(A). Each Order is based on one or more of
the findings in TSCA section 5(a)(3)(B): there is insufficient
information to permit a reasoned evaluation; in the absence of
sufficient information to permit a reasoned evaluation, the activities
associated with the PMN substances may present unreasonable risk to
human health or the environment; the substance is or will be produced
in substantial quantities, and enters or may reasonably be anticipated
to enter the environment in substantial quantities or there is or may
be significant (substantial) human exposure to the substance. Those
Orders require protective measures to limit exposures or otherwise
mitigate the potential unreasonable risk. The SNURs identify as
significant new uses any manufacturing, processing, use, distribution
in commerce, or disposal that does not conform to the restrictions
imposed by the underlying Orders, consistent with TSCA section 5(f)(4).
Where EPA determined that the PMN substance may present an
unreasonable risk of injury to human health via inhalation exposure,
the underlying TSCA section 5(e) Order required, among other things,
that potentially exposed employees wear specified respirators unless
actual measurements of the workplace air show that air-borne
concentrations of the PMN substance are below a New Chemical Exposure
Limit (NCEL) that is established by EPA to provide adequate protection
to human health. In addition to the actual NCEL concentration, the
comprehensive NCELs provisions in TSCA section 5(e) Orders, which are
modeled after Occupational Safety and Health Administration (OSHA)
Permissible Exposure Limits (PELs) provisions, include requirements
addressing performance criteria for sampling and analytical methods,
periodic monitoring, respiratory protection, and recordkeeping.
However, no comparable NCEL provisions currently exist in 40 CFR part
721, subpart B, for SNURs. Therefore, for these cases, the individual
SNURs in 40 CFR part 721, subpart E, will state that persons subject to
the SNUR who wish to pursue NCELs as an alternative to the Sec. 721.63
respirator requirements may request to do so under Sec. 721.30. EPA
expects that persons whose Sec. 721.30 requests to use the NCELs
approach for SNURs that are approved by EPA will be required to comply
with NCELs provisions that are comparable to those contained in the
corresponding TSCA section 5(e) Order for the same chemical substance.
PMN Numbers: P-15-442, P-15-443, P-15-444, P-15-445, P-15-446, P-
15-447, P-15-525, P-15-526, P-15-527, and P-15-528.
Chemical names: Rare earth doped zirconium oxide (generic).
CAS numbers: Not available.
Effective date of TSCA section 5(e) Order: January 25, 2018.
Basis for TSCA section 5(e) Order: The PMNs state that the generic
(non-confidential) use of the substances will be as catalysts. EPA
identified concern for lung toxicity and oncogenicity based on analogy
to respirable poorly soluble particulates and the crystalline structure
of the substances. The Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the
absence of sufficient information to permit a reasoned evaluation, the
substances may present an unreasonable risk of injury to human health
and the environment. The order was also issued under TSCA sections
5(a)(3)(B)(ii)(II) and 5(e)(1)(A)(ii)(II), based on a finding that the
substances will be produced in substantial quantities and that the
substances either enter or may reasonably be anticipated to enter the
environment in substantial quantities, or there is or may be
significant (or substantial) human exposure to the substances. To
protect against these risks, the Order requires:
1. Submit to EPA certain toxicity testing for both P-15-443 and P-
15-445 within the 18 and 60-month time limits specified on the Order.
2. Use of a National Institute of Occupational Safety and Health
(NIOSH)-certified respirator with an assigned protection factor (APF)
of at least 1,000 where there is a potential for inhalation exposure or
compliance with a NCEL of 0.07 mg/m\3\ as an 8-hour time-weighted
average to prevent inhalation exposure;
3. Establishment and use of a hazard communication program,
including human health precautionary statements on each label and in
the safety data sheet (SDS).
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the health effects of the PMN substances may be
potentially useful to characterize the effects of the PMN substances in
support of a request by the PMN submitter to modify the Order, or if a
manufacturer or processor is considering submitting a SNUN for a
significant new use that would be designated by this SNUR. The
submitter has agreed not to exceed the time limits in the Order without
performing specific pulmonary toxicity testing and carcinogenicity
testing on PMN substances P-15-443 and P-15-445.
CFR citation: 40 CFR 721.11173.
PMN Numbers: P-16-194, P-16-195, P-16-196, P-16-197, P-16-198, P-
16-199, P-16-460, P-16-461, P-16-462, P-16-463, and P-16-464.
Chemical names: Silane-treated aluminosilicate (generic).
CAS numbers: Not available.
Effective date of TSCA section 5(e) Order: January 22, 2018.
Basis for TSCA section 5(e) Order: The PMNs state that the generic
(non-confidential) use of the substances will be as process aids. Based
on analysis of test data on the PMN substances, EPA identified human
health concerns for cancer and non-cancer chronic toxicity effects
associated with the metal
[[Page 50841]]
impurities found in the PMN substances. Environmental effects were
identified for the metal constituents in the PMN substances. The Order
was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence of sufficient information to
permit a reasoned evaluation, the substances may present an
unreasonable risk of injury to human health and the environment. To
protect against these risks, the Order requires:
1. Submit to EPA metals content analysis of the material used to
manufacture the PMN substances.
2. Provide personal protective equipment to its workers to prevent
dermal exposure where there is potential for dermal exposure.
3. Use of a NIOSH-certified respirator with an APF of at least 50
where there is a potential for inhalation exposures.
4. Establishment and use of a hazard communication program,
including human health precautionary statements on each label and in
the SDS.
5. Not manufacture or process the PMN substances other than at
facilities equipped with pollution controls, such as a bag house, that
remove particulates from the air at 99% or greater efficiency.
6. Not use the PMN substances other than as described in the PMN.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the health effects of the PMN substances may be
potentially useful to characterize the effects of the PMN substances in
support of a request by the PMN submitter to modify the Order, or if a
manufacturer or processor is considering submitting a SNUN for a
significant new use that would be designated by this SNUR. The
submitter has agreed not to exceed the time limits in the Order without
sampling and analyzing the immediate precursor used to manufacture the
PMN substances via EPA Method 6010B for the following elements:
arsenic, barium, beryllium, cadmium, chromium, cobalt, copper, lead,
manganese, mercury, nickel, selenium, silver, vanadium, and zinc.
CFR citations: 40 CFR 721.11174.
PMN Number: P-16-307
Chemical Name: Heteropolycycliccarboxylic acid, 1,3-dihydro-
disubstituted-, polymer with 1,1'-methylenebis, reaction products with
silica (generic).
CAS Number: Not available.
Effective date of TSCA section 5(e) Order: January 5, 2018.
Basis for TSCA section 5(e) Order: The PMN states that the generic
(non-confidential) use of the substance will be an open, non-dispersive
use. Based on physical/chemical properties of the PMN substance and
structure activity relationship (SAR) analysis of test data on
analogous poorly, soluble respirable particles and isocyanates, EPA
identified concerns for lung effects and dermal and respiratory
sensitization. The Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(l)(A)(ii)(I) of TSCA, based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the substance may present an unreasonable risk of injury to
human health. To protect against these risks, the Order requires:
1. Manufacture of the PMN substance to contain no more than 0.1%
residual of free isocyanate by weight;
2. Use of personal protective equipment where there is a potential
for dermal exposure;
3. No manufacturing, processing, or use of the PMN substance in any
manner that generates a vapor, dust, mist, or aerosol;
4. Refraining from manufacture, processing or use for consumer use
or in commercial use where there is use in a consumer setting;
5. Manufacture, process, or use the PMN substance only in liquid
formulation; and
6. Establishment and use of a hazard communication program,
including human health precautionary statements on each label and in
the SDS.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about health effects of the PMN substance may be
potentially useful to characterize the effects of the PMN substance in
support of a request by the PMN submitter to modify the Order, or if a
manufacturer or processor is considering submitting a SNUN for a
significant new use that would be designated by this SNUR. EPA has also
determined that the results of acute toxicity testing and specific
target organ toxicity testing would help characterize the potential
human effects of the PMN substance. Although the Order does not require
these tests, the Order's restrictions remain in effect until the Order
is modified or revoked by EPA based on submission of this or relevant
information.
CFR citation: 40 CFR 721.11175.
PMN Number: P-17-176
Chemical name: Carbonic acid, alkyl carbomonocyclic ester
(generic).
CAS number: Not available.
Effective date of TSCA section 5(e) Order: February 21, 2018.
Basis for TSCA section 5(e) Order: The PMNs state that the generic
(non-confidential) use of the substance will be as a battery
ingredient. Based on toxicology data from an analogue, EPA has
identified possible human health concerns for developmental toxicity
and effects on the ovaries, adrenals and liver. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health. To protect against these risk, the Order
requires:
1. Submit to EPA certain toxicity testing within 3 years of the
notice of commencement of manufacturing (including import) of the PMN
substance;
2. Use of personal protective equipment to its workers to prevent
dermal exposure where there is a potential for dermal exposure;
3. Establishment and use of a hazard communication program,
including human health precautionary statements on each label and in
the SDS.
4. Refraining from domestic manufacture in the United States (i.e.,
import only); and
5. No release of the PMN substance into waters of the United States
exceeding 45 parts per billion.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the environmental and health effects of the PMN
substance may be potentially useful to characterize the effects of the
PMN substance in support of a request by the PMN submitter to modify
the Order, or if a manufacturer or processor is considering submitting
a SNUN for a significant new use that would be designated by this SNUR.
The submitter has agreed not to manufacture the PMN substance without
performing specific reproductive/developmental toxicity testing 3 years
from the notice of commencement. EPA has also determined that the
results of specific chronic aquatic toxicity testing would help
characterize the potential environmental effects of the PMN substance.
Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or relevant information.
CFR citation: 40 CFR 721.11176.
PMN Number: P-17-183.
[[Page 50842]]
Chemical name: 1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer
with 2-(chloromethyl)oxirane, reaction products with polyethylene-
polypropylene glycol 2-aminopropyl Me ether.
CAS number: 1627528-04-4.
Effective date of TSCA section 5(e) Order: February 28, 2018.
Basis for TSCA section 5(e) Order: The PMNs state that the generic
(non-confidential) use of the substance will be as a pigment wetting
and dispersing additive. Based on the surfactant potential of the PMN
compound, EPA has identified concerns for lung effects to workers if
respirable particulates or droplets are inhaled. The Order was issued
under TSCA sections 5(a)(3)(B)(i) and 5(e)(1)(A)(i), based on a finding
that the available information is insufficient to permit a reasoned
evaluation of the human health effects of the PMN substance. To protect
against these risks, the Order requires:
1. Establishment and use of a hazard communication program,
including human health precautionary statements on each label and in
the SDS;
2. Refraining from domestic manufacture in the United States (i.e.,
import only);
3. No manufacturing, processing, or using the PMN substance in any
manner that results in inhalation exposure to vapors, mists, aerosols
or dusts;
4. No use of the PMN substance other than the confidential uses
allowed by the Order; and
5. No use of the PMN substance in consumer products.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the health effects of the PMN substance may be
potentially useful to characterize the effects of the PMN substance in
support of a request by the PMN submitter to modify the Order, or if a
manufacturer or processor is considering submitting a SNUN for a
significant new use that would be designated by this SNUR. EPA has
determined that the results of specific physical-chemical properties
and acute and chronic pulmonary toxicity testing would help
characterize the potential health effects of the PMN substance.
Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or relevant information.
CFR citation: 40 CFR 721.11177.
PMN Number: P-17-232.
Chemical name: Copolyamide of an aromatic dicarboxylic acid and a
mixture of diamines (generic).
CAS number: Not available.
Effective date of TSCA section 5(e) Order: March 5, 2018.
Basis for TSCA section 5(e) Order: The PMN states that the generic
(non-confidential) use of the substance is as an engineering
thermoplastic. Based on SAR analysis on structurally similar poorly
soluble particles, EPA identified concerns for lung effects to workers
if respirable particles are present. The Order was issued under TSCA
section 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the substance may present an unreasonable risk of injury to
human health. To protect against these risk, the Order requires:
Manufacture the PMN substance with a particle size of greater than
10 microns.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the health effects of the PMN substance may be
potentially useful to characterize the effects of the PMN substance in
support of a request by the PMN submitter to modify the Order, or if a
manufacturer or processor is considering submitting a SNUN for a
significant new use that would be designated by this SNUR. EPA has also
determined that the results of pulmonary toxicity testing would help
characterize the potential human effects of the PMN substance. Although
the Order does not require this testing, the Order's restrictions
remain in effect until the Order is modified or revoked by EPA based on
submission of this or relevant information.
CFR citation: 40 CFR 721.11178.
PMN Number: P-17-257.
Chemical name: Single-walled carbon nanotubes.
CAS number: Not available.
Effective date of TSCA section 5(e) Order: January 17, 2018.
Basis for TSCA section 5(e) Order: The PMN states that the generic
(non-confidential) use of the substance will be as an additive in
composite materials for mechanical, thermal, and conductivity
improvements. Based on analysis of analogous carbon nanotubes, EPA
identified concerns for pulmonary toxicity. Based on analogous carbon
nanotubes, EPA also identified potential toxicity to aquatic organisms
if the PMN substance is released to water. The order was issued under
TSCA sections 5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I) based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the PMN substance may present an unreasonable risk of
injury to human health and the environment. To protect against these
risks, the Order requires:
1. Submit to EPA certain toxicity testing before manufacturing
(including import) by the times specified in the Order.
2. Provide personal protective equipment to its workers to prevent
dermal exposure where there is a potential for dermal exposure.
3. Provide NIOSH certified respirators with an APF of at least 50
to its workers to prevent inhalation exposure.
4. No use of the PMN substance in application methods that generate
a dust, vapor, mist or aerosol.
5. Use the PMN substance for industrial uses only.
6. Use the PMN substance only for the confidential uses allowed in
the Order.
7. No release of the PMN substance to water.
8. Disposal of the PMN substance only via landfill or incineration.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the environmental and health effects of the PMN
substance may be potentially useful to characterize the effects of the
PMN substance in support of a request by the PMN submitter to modify
the Order, or if a manufacturer or processor is considering submitting
a SNUN for a significant new use that would be designated by this SNUR.
The submitter has agreed not to manufacture the PMN substance without
performing specific physical property and pulmonary toxicity testing.
EPA has also determined that the results of specific chronic aquatic
toxicity testing would help characterize the potential environmental
effects of the PMN substance. Although the Order does not require these
tests, the Order's restrictions remain in effect until the Order is
modified or revoked by EPA based on submission of this or relevant
information.
CFR citation: 40 CFR 721.11179.
PMN Number: P-17-283.
Chemical name: Arenesulfonic acid, alkyl derivatives, metal salts
(generic).
CAS number: Not available.
Effective date of TSCA section 5(e) Order: February 6, 2018.
Basis for TSCA section 5(e) Order: The PMN states that the generic
(non-confidential) use of the substance will be as a lubricating oil
additive for automotive engine oils. Based on
[[Page 50843]]
analysis of test data on the PMN substance, EPA identified concern for
corrosion to skin, eyes, mucous membranes, and lungs. There is also
concern for surfactant effects on the lung based on surfactant
properties of the compounds. There is also concern for acute toxicity,
mutagenicity, irritation, and sensitization based on submitted analogue
test data. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I)
and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of
sufficient information to permit a reasoned evaluation, the substance
may present an unreasonable risk of injury to human health and the
environment. The Order was also issued under TSCA sections
5(a)(3)(B)(ii)(II) and 5(e)(1)(A)(ii)(II), based on a finding that the
substance is or will be produced in substantial quantities and that the
substance wither enters or may reasonably be anticipated to enter the
environment in substantial quantities, or there is or may be
significant (or substantial) human exposure to the substance. To
protect against these risks, the Order requires:
1. Submit to EPA certain toxicity testing within six months of
filing a notice of commencement (NOC) to EPA;
2. Use of personal protective equipment where there is a potential
for dermal exposure;
3. Establishment and use of a hazard communication program,
including human health precautionary statements on each label and in
the SDS; and
4. Refrain from manufacturing, processing, or using the PMN
substance in any manner that produces vapor, mist, spray or aerosol.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the health effects of the PMN substance may be
potentially useful to characterize the effects of the PMN substance in
support of a request by the PMN submitter to modify the Order, or if a
manufacturer or processor is considering submitting a SNUN for a
significant new use that would be designated by this SNUR. The
submitter has agreed not to manufacture the PMN substance without
performing sensitization testing. EPA has also determined that the
results of specific physical-chemical properties and acute and chronic
pulmonary toxicity testing would help characterize the potential health
effects of the PMN substance. Although the Order does not require these
tests, the Order's restrictions remain in effect until the Order is
modified or revoked by EPA based on submission of this or relevant
information.
CFR citation: 40 CFR 721.11180.
PMN Number: P-17-353.
Chemical name: Heteromonocycle, 2-[(bicarbomonocycle-2-
substituted)alkyl]- (generic).
CAS number: Not available.
Effective date of TSCA section 5(e) Order: February 26, 2018.
Basis for TSCA section 5(e) Order: The PMN states that the generic
(non-confidential) use of the substance will be as an additive in resin
manufacture. Based on information on analogous substances, EPA has
identified concerns for irritation to the eye, lung, and mucous
membranes, skin and lung sensitization, oncogenicity, developmental
toxicity, male reproductive toxicity, liver toxicity, and kidney
toxicity. Ecotoxicity hazard concerns were high based on EcoSAR
analysis of analogous chemical. The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the PMN substance may present an unreasonable risk of
injury to human health and the environment. To protect against these
risks, the Order requires:
1. Refraining from domestic manufacture in the United States (i.e.,
import only);
2. Use of the PMN substance only for the confidential use allowed
in the Order;
3. No processing and use of the PMN substance using methods that
may generate a spray, mist or aerosol.
4. Use of personal protective equipment where there is a potential
for dermal exposure.
5. Establishment and use of a hazard communication program,
including human health precautionary statements on each label and in
the SDS.
6. No release of the PMN substance into the waters of the United
States.
The SNUR designates as a ``significant new use'' the absence of
these protective measures.
Potentially useful information: EPA has determined that certain
information about the environmental and health effects of the PMN
substance may be potentially useful to characterize the effects of the
PMN substance in support of a request by the PMN submitter to modify
the Order, or if a manufacturer or processor is considering submitting
a SNUN for a significant new use that would be designated by this SNUR.
EPA has also determined that the results of specific acute and chronic
aquatic toxicity testing, skin sensitization testing, carcinogenicity
testing, and specific target organ testing would help characterize the
potential human effects of the PMN substance. Although the Order does
not require these tests, the Order's restrictions remain in effect
until the Order is modified or revoked by EPA based on submission of
this or relevant information.
CFR citation: 40 CFR 721.11181.
V. Rationale and Objectives of the Rule
A. Rationale
During review of the PMNs submitted for the chemical substances
that are subject to these SNURs, EPA concluded that for all 28 chemical
substances, regulation was warranted under TSCA section 5(e), pending
the development of information sufficient to make reasoned evaluations
of the health or environmental effects of the chemical substances. The
basis for such findings is outlined in Unit IV. Based on these
findings, TSCA section 5(e) Orders requiring the use of appropriate
exposure controls were negotiated with the PMN submitters.
The SNURs identify as significant new uses any manufacturing,
processing, use, distribution in commerce, or disposal that does not
conform to the restrictions imposed by the underlying Orders,
consistent with TSCA section 5(f)(4).
B. Objectives
EPA is issuing these SNURs for specific chemical substances which
have undergone premanufacture review because the Agency wants to
achieve the following objectives with regard to the significant new
uses designated in this rule:
EPA will receive notice of any person's intent to
manufacture or process a listed chemical substance for the described
significant new use before that activity begins.
EPA will have an opportunity to review and evaluate data
submitted in a SNUN before the notice submitter begins manufacturing or
processing a listed chemical substance for the described significant
new use.
EPA will be able to either determine that the prospective
manufacture or processing is not likely to present an unreasonable
risk, or to take necessary regulatory action associated with any other
determination, before the described significant new use of the chemical
substance occurs.
EPA will identify as significant new uses any
manufacturing, processing, use, distribution in commerce, use, or
disposal that does not conform to the restrictions imposed by the
underlying Orders, consistent with TSCA section 5(f)(4).
[[Page 50844]]
Issuance of a SNUR for a chemical substance does not signify that
the chemical substance is listed on the TSCA Chemical Substance
Inventory (TSCA Inventory). Guidance on how to determine if a chemical
substance is on the TSCA Inventory is available on the internet at
https://www.epa.gov/opptintr/existingchemicals/pubs/tscainventory/.
VI. Direct Final Procedures
EPA is issuing these SNURs as a direct final rule. The effective
date of this rule is December 10, 2018without further notice, unless
EPA receives written adverse comments before November 9, 2018.
If EPA receives written adverse comments on one or more of these
SNURs before November 9, 2018, EPA will withdraw the relevant sections
of this direct final rule before its effective date.
This rule establishes SNURs for a number of chemical substances.
Any person who submits adverse comments must identify the chemical
substance and the new use to which it applies. EPA will not withdraw a
SNUR for a chemical substance not identified in the comment.
VII. Applicability of the Significant New Use Designation
To establish a significant new use, EPA must determine that the use
is not ongoing. The chemical substances subject to this rule have
undergone premanufacture review. In cases where EPA has not received an
NOC and the chemical substance has not been added to the TSCA
Inventory, no person may commence such activities without first
submitting a PMN. Therefore, for chemical substances for which an NOC
has not been submitted EPA concludes that the designated significant
new uses are not ongoing.
When chemical substances identified in this rule are added to the
TSCA Inventory, EPA recognizes that, before the rule is effective,
other persons might engage in a use that has been identified as a
significant new use. However, TSCA section 5(e) Orders have been issued
for all of the chemical substances, and the PMN submitters are
prohibited by the TSCA section 5(e) Orders from undertaking activities
which will be designated as significant new uses. The identities of 26
of the 28 chemical substances subject to this rule have been claimed as
confidential and EPA has received no post-PMN bona fide submissions
(per Sec. Sec. 720.25 and 721.11) for a chemical substance covered by
this action. Based on this, the Agency believes that it is highly
unlikely that any of the significant new uses described in the
regulatory text of this rule are ongoing.
Therefore, EPA designates October 10, 2018 as the cutoff date for
determining whether the new use is ongoing. The objective of EPA's
approach has been to ensure that a person could not defeat a SNUR by
initiating a significant new use before the effective date of the
direct final rule.
Persons who begin commercial manufacture or processing of the
chemical substances for a significant new use identified as of that
date will have to cease any such activity upon the effective date of
the final rule. To resume their activities, these persons will have to
first comply with all applicable SNUR notification requirements and
wait until EPA has conducted a review of the notice, made an
appropriate determination on the notice, and has taken such actions as
are required with that determination.
VIII. Development and Submission of Information
EPA recognizes that TSCA section 5 does not require developing any
particular new information (e.g., generating test data) before
submission of a SNUN. There is an exception: Development of test data
is required where the chemical substance subject to the SNUR is also
subject to a rule, order or consent agreement under TSCA section 4 (see
TSCA section 5(b)(1)).
In the absence of a TSCA section 4 test rule covering the chemical
substance, persons are required only to submit information in their
possession or control and to describe any other information known to or
reasonably ascertainable by them (see 40 CFR 720.50). However, upon
review of PMNs and SNUNs, the Agency has the authority to require
appropriate testing. Unit IV. lists potentially useful information for
all of the listed SNURs. Descriptions of the information are provided
for informational purposes. EPA strongly encourages persons, before
performing any testing, to consult with the Agency pertaining to
protocol selection. Furthermore, pursuant to TSCA section 4(h), which
pertains to reduction of testing in vertebrate animals, EPA encourages
consultation with the Agency on the use of alternative test methods and
strategies (also called New Approach Methodologies, or NAMs), if
available, to generate the recommended test data. EPA encourages dialog
with Agency representatives to help determine how best the submitter
can meet both the data needs and the objective of TSCA section 4(h).
In certain of the TSCA section 5(e) Orders for the chemical
substances regulated under this rule, EPA has established production
volume or time limits in view of the lack of data on the potential
health and environmental risks that may be posed by the significant new
uses or increased exposure to the chemical substances. These limits
cannot be exceeded unless the PMN submitter first submits the results
of toxicity tests that would permit a reasoned evaluation of the
potential risks posed by these chemical substances. Listings of the
information required in the TSCA section 5(e) Orders are included in
Unit IV. The SNURs contain the same production volume limits as the
TSCA section 5(e) Orders. Exceeding these production limits is defined
as a significant new use. Persons who intend to exceed the production
limit must notify the Agency by submitting a SNUN at least 90 days in
advance of commencement of non-exempt commercial manufacture or
processing.
Any request by EPA for the triggered and pended testing described
in the Orders was made based on EPA's consideration of available
screening-level data, if any, as well as other available information on
appropriate testing for the PMN substances. Further, any such testing
request on the part of EPA that includes testing on vertebrates was
made after consideration of available toxicity information,
computational toxicology and bioinformatics, and high-throughput
screening methods and their prediction models.
Potentially useful information identified in Unit IV. may not be
the only means of addressing the potential risks of the chemical
substance. However, submitting a SNUN without any test data may
increase the likelihood that EPA will take action under TSCA section
5(e), particularly if satisfactory test results have not been obtained
from a prior PMN or SNUN submitter. EPA recommends that potential SNUN
submitters contact EPA early enough so that they will be able to
conduct the appropriate tests.
SNUN submitters should be aware that EPA will be better able to
evaluate SNUNs which provide detailed information on the following:
Human exposure and environmental release that may result
from the significant new use of the chemical substances.
Information on risks posed by the chemical substances
compared to risks posed by potential substitutes.
[[Page 50845]]
IX. Procedural Determinations
By this rule, EPA is establishing certain significant new uses
which have been claimed as CBI subject to Agency confidentiality
regulations at 40 CFR part 2 and 40 CFR part 720, subpart E. Absent a
final determination or other disposition of the confidentiality claim
under 40 CFR part 2 procedures, EPA is required to keep this
information confidential. EPA promulgated a procedure to deal with the
situation where a specific significant new use is CBI, at Sec.
721.1725(b)(1).
Under these procedures a manufacturer or processor may request EPA
to determine whether a proposed use would be a significant new use
under the rule. The manufacturer or processor must show that it has a
bona fide intent to manufacture or process the chemical substance and
must identify the specific use for which it intends to manufacture or
process the chemical substance. If EPA concludes that the person has
shown a bona fide intent to manufacture or process the chemical
substance, EPA will tell the person whether the use identified in the
bona fide submission would be a significant new use under the rule.
Since most of the chemical identities of the chemical substances
subject to these SNURs are also CBI, manufacturers and processors can
combine the bona fide submission under the procedure in Sec.
721.1725(b)(1) with that under Sec. 721.11 into a single step.
If EPA determines that the use identified in the bona fide
submission would not be a significant new use, i.e., the use does not
meet the criteria specified in the rule for a significant new use, that
person can manufacture or process the chemical substance so long as the
significant new use trigger is not met. In the case of a production
volume trigger, this means that the aggregate annual production volume
does not exceed that identified in the bona fide submission to EPA.
Because of confidentiality concerns, EPA does not typically disclose
the actual production volume that constitutes the use trigger. Thus, if
the person later intends to exceed that volume, a new bona fide
submission would be necessary to determine whether that higher volume
would be a significant new use.
X. SNUN Submissions
According to Sec. 721.1(c), persons submitting a SNUN must comply
with the same notification requirements and EPA regulatory procedures
as persons submitting a PMN, including submission of test data on
health and environmental effects as described in 40 CFR 720.50. SNUNs
must be submitted on EPA Form No. 7710-25, generated using e-PMN
software, and submitted to the Agency in accordance with the procedures
set forth in 40 CFR 720.40 and 721.25. E-PMN software is available
electronically at https://www.epa.gov/opptintr/newchems.
XI. Economic Analysis
EPA has evaluated the potential costs of establishing SNUN
requirements for potential manufacturers and processors of the chemical
substances subject to this rule. EPA's complete economic analysis is
available in the docket under docket ID number EPA-HQ-OPPT-2018-0649.
XII. Statutory and Executive Order Reviews
A. Executive Order 12866
This action establishes SNURs for several new chemical substances
that were the subject of PMNs, or TSCA section 5(e) Orders. The Office
of Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993).
B. Paperwork Reduction Act (PRA)
According to PRA (44 U.S.C. 3501 et seq.), an agency may not
conduct or sponsor, and a person is not required to respond to a
collection of information that requires OMB approval under PRA, unless
it has been approved by OMB and displays a currently valid OMB control
number. The OMB control numbers for EPA's regulations in title 40 of
the CFR, after appearing in the Federal Register, are listed in 40 CFR
part 9, and included on the related collection instrument or form, if
applicable. EPA is amending the table in 40 CFR part 9 to list the OMB
approval number for the information collection requirements contained
in this action. This listing of the OMB control numbers and their
subsequent codification in the CFR satisfies the display requirements
of PRA and OMB's implementing regulations at 5 CFR part 1320. This
Information Collection Request (ICR) was previously subject to public
notice and comment prior to OMB approval, and given the technical
nature of the table, EPA finds that further notice and comment to amend
it is unnecessary. As a result, EPA finds that there is ``good cause''
under section 553(b)(3)(B) of the Administrative Procedure Act (5
U.S.C. 553(b)(3)(B)) to amend this table without further notice and
comment.
The information collection requirements related to this action have
already been approved by OMB pursuant to PRA under OMB control number
2070-0012 (EPA ICR No. 574). This action does not impose any burden
requiring additional OMB approval. If an entity were to submit a SNUN
to the Agency, the annual burden is estimated to average between 30 and
170 hours per response. This burden estimate includes the time needed
to review instructions, search existing data sources, gather and
maintain the data needed, and complete, review, and submit the required
SNUN.
Send any comments about the accuracy of the burden estimate, and
any suggested methods for minimizing respondent burden, including
through the use of automated collection techniques, to the Director,
Collection Strategies Division, Office of Environmental Information
(2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460-0001. Please remember to include the OMB control
number in any correspondence, but do not submit any completed forms to
this address.
C. Regulatory Flexibility Act (RFA)
On February 18, 2012, EPA certified pursuant to RFA section 605(b)
(5 U.S.C. 601 et seq.), that promulgation of a SNUR does not have a
significant economic impact on a substantial number of small entities
where the following are true:
1. A significant number of SNUNs would not be submitted by small
entities in response to the SNUR.
2. The SNUR submitted by any small entity would not cost
significantly more than $8,300. A copy of that certification is
available in the docket for this action.
This action is within the scope of the February 18, 2012
certification. Based on the Economic Analysis discussed in Unit XI. and
EPA's experience promulgating SNURs (discussed in the certification),
EPA believes that the following are true:
A significant number of SNUNs would not be submitted by
small entities in response to the SNUR.
Submission of the SNUN would not cost any small entity
significantly more than $8,300.
Therefore, the promulgation of the SNUR would not have a
significant economic impact on a substantial number of small entities.
D. Unfunded Mandates Reform Act (UMRA)
Based on EPA's experience with proposing and finalizing SNURs,
State, local, and Tribal governments have not been impacted by these
rulemakings, and EPA does not have any reasons to
[[Page 50846]]
believe that any State, local, or Tribal government will be impacted by
this action. As such, EPA has determined that this action does not
impose any enforceable duty, contain any unfunded mandate, or otherwise
have any effect on small governments subject to the requirements of
UMRA sections 202, 203, 204, or 205 (2 U.S.C. 1501 et seq.).
E. Executive Order 13132
This action will not have a substantial direct effect on States, on
the relationship between the national government and the States, or on
the distribution of power and responsibilities among the various levels
of government, as specified in Executive Order 13132, entitled
``Federalism'' (64 FR 43255, August 10, 1999).
F. Executive Order 13175
This action does not have Tribal implications because it is not
expected to have substantial direct effects on Indian Tribes. This
action does not significantly nor uniquely affect the communities of
Indian Tribal governments, nor does it involve or impose any
requirements that affect Indian Tribes. Accordingly, the requirements
of Executive Order 13175, entitled ``Consultation and Coordination with
Indian Tribal Governments'' (65 FR 67249, November 9, 2000), do not
apply to this action.
G. Executive Order 13045
This action is not subject to Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997), because this is not an
economically significant regulatory action as defined by Executive
Order 12866, and this action does not address environmental health or
safety risks disproportionately affecting children.
H. Executive Order 13211
This action is not subject to Executive Order 13211, entitled
``Actions Concerning Regulations That Significantly Affect Energy
Supply, Distribution, or Use'' (66 FR 28355, May 22, 2001), because
this action is not expected to affect energy supply, distribution, or
use and because this action is not a significant regulatory action
under Executive Order 12866.
I. National Technology Transfer and Advancement Act (NTTAA)
In addition, since this action does not involve any technical
standards, NTTAA section 12(d) (15 U.S.C. 272 note), does not apply to
this action.
J. Executive Order 12898
This action does not entail special considerations of environmental
justice related issues as delineated by Executive Order 12898, entitled
``Federal Actions to Address Environmental Justice in Minority
Populations and Low-Income Populations'' (59 FR 7629, February 16,
1994).
XIII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects
40 CFR Part 9
Environmental protection, Reporting and recordkeeping requirements.
40 CFR Part 721
Environmental protection, Chemicals, Hazardous substances,
Reporting and recordkeeping requirements.
Dated: October 1, 2018.
Jeffery T. Morris,
Director, Office of Pollution Prevention and Toxics.
Therefore, 40 CFR parts 9 and 721 are amended as follows:
PART 9--[AMENDED]
0
1. The authority citation for part 9 continues to read as follows:
Authority: 7 U.S.C. 135 et seq., 136-136y; 15 U.S.C. 2001, 2003,
2005, 2006, 2601-2671; 21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33
U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 1321, 1326, 1330,
1342, 1344, 1345 (d) and (e), 1361; E.O. 11735, 38 FR 21243, 3 CFR,
1971-1975 Comp. p. 973; 42 U.S.C. 241, 242b, 243, 246, 300f, 300g,
300g-1, 300g-2, 300g-3, 300g-4, 300g-5, 300g-6, 300j-1, 300j-2,
300j-3, 300j-4, 300j-9, 1857 et seq., 6901-6992k, 7401-7671q, 7542,
9601-9657, 11023, 11048.
0
2. In Sec. 9.1, add the following sections in numerical order under
the undesignated center heading ``Significant New Uses of Chemical
Substances'' to read as follows:
Sec. 9.1 OMB approvals under the Paperwork Reduction Act.
* * * * *
------------------------------------------------------------------------
OMB control
40 CFR citation No.
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
Significant New Uses of Chemical Substances
------------------------------------------------------------------------
* * * * *
721.11173............................................... 2070-0012
721.11174............................................... 2070-0012
721.11175............................................... 2070-0012
721.11176............................................... 2070-0012
721.11177............................................... 2070-0012
721.11178............................................... 2070-0012
721.11179............................................... 2070-0012
721.11180............................................... 2070-0012
721.11181............................................... 2070-0012
* * * * *
------------------------------------------------------------------------
* * * * *
PART 721--[AMENDED]
0
3. The authority citation for part 721 continues to read as follows:
Authority: 15 U.S.C. 2604, 2607, and 2625(c).
0
4. Add Sec. 721.11173 to subpart E to read as follows:
Sec. 721.11173 Rare earth doped zirconium oxide (generic).
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substances identified generically as rare
earth doped zirconium oxide (P-15-442, P-15-443, P-15-444, P-15-445, P-
15-446, P-15-447, P-15-525, P-15-526, P-15-527, and P-15-528) are
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been reacted (cured).
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(4), (when determining which persons are reasonably likely to
be exposed as required for Sec. 721.63(a)(4), engineering control
measures (e.g., enclosure or confinement of the operation, general and
local ventilation) or administrative control measures (e.g., workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible), (a)(5) (respirators must provide a National
Institute for Occupational Safety and Health (NIOSH) assigned
protection factor of at least 1000), (a)(6) (particulate), (b)
(concentration set at 1.0%), and (c).
[[Page 50847]]
(A) As an alternative to the respirator requirements in paragraph
(a)(2)(i) of this section, a manufacturer or processor may choose to
follow the new chemical exposure limit (NCEL) provision listed in the
TSCA section 5(e) Order for this substance. The NCEL is 0.07 mg/m\3\ as
an 8-hour time weighted average. Persons who wish to pursue NCELs as an
alternative to Sec. 721.63 respirator requirements may request to do
so under Sec. 721.30. Persons whose Sec. 721.30 requests to use the
NCELs approach are approved by EPA will be required to follow NCELs
provisions comparable to those contained in the corresponding TSCA
section 5(e) Order.
(B) [Reserved]
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e)(concentration set at 1.0%), (f), (g)(1)(ii),
(g)(2)(ii), (iii), (iv)(use respiratory protection or maintain
workplace airborne concentrations at or below an 8-hour time-weighted
average of 0.07 mg/m\3\), and (g)(5). Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(p) (18 months).
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (d) and (f) through (i) are applicable to
manufacturers and processors of the substances.
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
0
5. Add Sec. 721.11174 to subpart E to read as follows:
Sec. 721.11174 Silane-treated aluminosilicate (generic).
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substances identified generically as
silane-treated aluminosilicate (PMNs P-16-194, P-16-195, P-16-196, P-
16-197, P-16-198, P-16-199, P-16-460, P-16-461, P-16-462, P-16-463, and
P-16-464) are subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section. The
requirements of this section do not apply to quantities of the
substances after they have been completely incorporated into a polymer
matrix.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(4), (when determining which persons are reasonably likely to
be exposed as required for Sec. 721.63(a)(4), engineering control
measures (e.g. enclosure or confinement of operation, general and local
ventilation) or administrative control measures (e.g. workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible), (a)(5) (respirators must provide a National
Institute for Occupational Safety and Health assigned protection factor
of at least 50), (a)(6) (particulate), (b) (concentration set at 0.1%),
and (c).
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e) (concentration set at 0.1%), (f), (g)(1)(ii),
(iii), (iv), (v), (vi), (vii), (viii), (ix), (g)(2)(i), (ii), (iii),
(iv), (v), and (g)(5). Alternative hazard and warning statements that
meet the criteria of the Globally Harmonized System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80. It is a significant new use to
manufacture the substances without sampling and analyzing the immediate
precursor used to manufacture the substances according to the terms
specified in the 5(e) Order for the following elements: Arsenic,
barium, beryllium, cadmium, chromium, cobalt, copper, lead, manganese,
mercury, nickel, selenium, silver, vanadium, and zinc. It is a
significant new use to manufacture the substances at facilities other
than those equipped with pollution controls, such as a bag house, that
remove particulates from the air at 99% or greater efficiency. It is a
significant new use to process the substances other than in an enclosed
system that does not allow for the release of particulates or at
facilities equipped with pollution controls, such as a bag house, that
remove particulates from the air at 99% or greater efficiency.
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (d), (f), (g), (h), and (i) are applicable to
manufacturers and processors of this substance.
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
(3) Determining whether a specific use is subject to this section.
The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.
0
6. Add Sec. 721.11175 to subpart E to read as follows:
Sec. 721.11175 Heteropolycycliccarboxylic acid, 1,3-dihydro-
disubstituted-, polymer with 1,1'-methylenebis, reaction products with
silica (generic).
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance generically identified as
heteropolycycliccarboxylic acid, 1,3-dihydro-disubstituted-, polymer
with 1,1'-methylenebis, reaction products with silica (P-16-307) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been reacted (cured).
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (a)(2)(i), (ii), (iii), (a)(3), (a)(6) (particulate),
(when determining which persons are reasonably likely to be exposed as
required for Sec. 721.63(a)(1), engineering control measures (e.g.
enclosure or confinement of the operation, general and local
ventilation) or administrative control measures (e.g. workplace
policies and procedures) shall be considered and implemented to prevent
exposures, where feasible), (b) (concentration set at 1.0%), and (c).
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(i),
(ii), (g)(2)(i), (ii), (iii), (v), and (g)(5). Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80. It is a significant new use to
manufacture, process, or use the substance for consumer use or for
commercial uses that could introduce the substance into a consumer
setting. It is a significant new use to manufacture, process, or use
the substance other than in a liquid formulation. It is a significant
new use to manufacture the PMN substance to contain more than 0.1%
residual isocyanate by weight. It is a significant new use to
manufacture, process, or use the substance in any manner that results
in generation of a vapor, dust, mist or aerosol.
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
[[Page 50848]]
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
0
7. Add Sec. 721.11176 to subpart E to read as follows:
Sec. 721.11176 Carbonic acid, alkyl carbomonocyclic ester (generic).
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
carbonic acid, alkyl carbomonocyclic ester (PMN P-17-176) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (a)(2), (a)(2)(i), (iv), (a)(3), (a)(6) (particulate),
(a)(6)(v), (vi), (when determining which persons are reasonable likely
to be exposed as required for Sec. 721.63(a)(1), engineering control
measures (e.g. enclosure or confinement of the operation, general and
local ventilation) or administrative control measures (e.g. workplace
policies and procedures) shall be considered and implemented to prevent
exposures, where feasible), (b)(concentration set at 1.0%), and (c).
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e)(concentration set at 1.0%), (f), (g)(1)(iv), (v),
(vi), (ix), (g)(2)(i), (v), (g)(3)(i), (ii), (g)(4) (do not release to
water above 45 parts per billion), and (g)(5). Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f) and (p)(3 years).
(iv) Release to water. Release to water requirements as specified
in Sec. 721.90(a)(4), (b)(4), and (c)(4) where N = 45 ppb.
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), (k).
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
0
8. Add Sec. 721.11177 to subpart E to read as follows:
Sec. 721.11177 1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer
with 2-(chloromethyl)oxirane, reaction products with polyethylene-
polypropylene glycol 2-aminopropyl Me ether.
(a) Chemical substance and significant new used subject to
reporting. (1) The chemical substance identified as 1,3-propanediol, 2-
ethyl-2-(hydroxymethyl)-, polymer with 2-(chloromethyl)oxirane,
reaction products with polyethylene-polypropylene glycol 2-aminopropyl
Me ether (PMN P-17-183, CAS No 1627528-04-4) is subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section. The requirements of this section do not apply
to quantities of the substance after they have been reacted (cured).
(2) The significant new uses are:
(i) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(ii),
(g)(2)(ii), and (g)(5). Alternative hazard and warning statements that
meet the criteria of the Globally Harmonized System and OSHA Hazard
Communication Standard may be used.
(ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), (o). It is a significant new use
to process or use the substance in any manner way that results in
generation of a vapor, dust, mist or aerosol.
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a), (b), (c), (f) through (i) are applicable to manufacturers
and processors of this substance.
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
0
9. Add Sec. 721.11178 to subpart E to read as follows:
Sec. 721.11178 Copolyamide of an aromatic dicarboxylic acid and a
mixture of diamines (generic).
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
copolyamide of an aromatic dicarboxylic acid and a mixture of diamines
(PMN P-17-232) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80. It is a significant new use to
manufacture the substance with a particle size less than 10 microns.
(ii) [Reserved]
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (c) and (i).
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
0
10. Add Sec. 721.11179 to subpart E to read as follows:
Sec. 721.11179 Single-walled carbon nanotubes.
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified as single-walled
carbon nanotubes (PMN P-17-257) is subject to reporting under this
section for the significant new uses described in paragraph (a)(2) of
this section. The requirements of this section do not apply to
quantities of the substances that have been:
(i) Embedded or incorporated into a polymer matrix that itself has
been reacted (cured);
(ii) Embedded in a permanent solid polymer form that is not
intended to undergo further processing, except mechanical processing;
or
(iii) Incorporated into an article as defined at 40 CFR 720.3(c).
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (a)(2)(i), (a)(3), (a)(4), (when determining which
persons are reasonable likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measure (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible), (a)(5)(respirators must provide a National Institute
for Occupational Safety and Health assigned protection factor of at
least 50), (a)(6) (particulate), and (c).
(ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), (p) (6 months), (y)(1), and
(y)(2). (It is a significant new use to process or use the substance
for non-industrial use except for the confidential non-industrial use
described in the 5(e) Order).
[[Page 50849]]
(iii) Disposal. Requirements as specified in Sec. 721.85(a)(1),
(a)(2), (b)(1), (b)(2), (c)(1), (c)(2).
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), (c)(1).
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (e), (j), and (k) are applicable to manufacturers
and processors of this substance.
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
(3) Determining whether a specific use is subject to this section.
The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.
0
11. Add Sec. 721.11180 to subpart E to read as follows:
Sec. 721.11180 Arenesulfonic acid, alkyl derivatives, metal salts
(generic).
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
arenesulfonic acid, alkyl derivatives, metal salts (PMN P-17-283) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (a)(2)(i), (iii), (a)(3), (when determining which persons
are reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g. enclosure or confinement of
operation, general and local ventilation) or administrative control
measures (e.g. workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible), (b)
(concentration set at 1.0%), and (c).
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(skin
sensitization), (eye irritation), (lung effects), (skin corrosion),
(g)(2)(i), (iii), (v), and (g)(5). Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(p) (6 months). It is a significant new use
to manufacture, process or use the substance in any manner way that
results in generation of a vapor, mist, spray, or aerosol.
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i).
(2) Limitations or revocation of certain notification requirements.
The provision of Sec. 721.185 apply to this section.
0
12. Add Sec. 721.11181 to subpart E to read as follows:
Sec. 721.11181 Heteromonocycle, 2-[(bicarbomonocycle-2-
substituted)alkyl]- (generic).
(a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
heteromonocycle, 2-[(bicarbomonocycle-2-substituted)alkyl]- (PMN P-17-
353) is subject to reporting under this section for the significant new
uses described in paragraph (a)(2) of this section. The requirements of
this section do not apply to quantities of the substance after they
have been reacted (cured).
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (a)(2)(i), (ii), (iii), (iv), (a)(3), (when determining
which persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g. enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g. workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible), (b) (concentration set at 0.1%), and (c).
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (e) (concentration set at 0.1%), (f), (g)(1),
(g)(1)(iv), (vi), (vii), (ix), (mutagenicity), (eye, skin, lung, and
mucous membrane irritation), (skin and lung sensitization), (g)(2)(i),
(ii), (iii), (v), (avoid workplace airborne concentrations), (g)(3)(i),
(ii), (g)(4)(iii), and (g)(5). Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities: Requirements
as specified in Sec. 721.80(f) and (k). It is a significant new use to
process or use the substance in any manner that generates a vapor,
spray, mist, or aerosol.
(iv) Release to water. Requirements as specified in Sec.
721.90(b)(1) and (c)(1).
(b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) and (k) are applicable to manufacturers and
processors of this substance.
(2) Limitations or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
(3) Determining whether a specific use is subject to this section.
The provisions of Sec. 721.1725(b)(1) apply to paragraph (a)(2)(iii)
of this section.
[FR Doc. 2018-21871 Filed 10-9-18; 8:45 am]
BILLING CODE 6560-50-P